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This study describes the use of computational modelling and statistical techniques to ad-
dress three topics in the field of steroid hormone research. The first is the hypocortisolism
seen in the South African Angora goat. In a comparative analysis the construction, pa-
rameterisation and validation of a model describing the Δ4 and Δ5 pathways in both the
ovine and Angora goat species are completed. With these models the issue of identifying
a possible treatment target is addressed. The second topic is the steroidogenic activity
in the human liver. This includes the construction, parameterisation and validation of
a model describing the relative conversion of classic androgens and 11-oxygenated an-
drogens to their respective 5α or 5β reduction products in the human liver. The model
indicates that under physiological steady state conditions the 5β reduction of both the
classic androgens and the 11-oxygenated androgens are the preferred reaction. The third
and final topic discussed in this study is the steroidogenic activity in prostate cancer
C42B cells. The construction, parameterisation and validation of a model describing
the steroid hormone biosynthesis in the C42B castration resistant prostate cancer cell
line is included. Three possible treatment targets for castration resistant prostate cancer
in C42B cells are identified. This study also describes the development of an add-on
Mathematica package, IdentifiabilityAnalysis, which simplifies the process of model




Hierdie studie beskryf die gebruik van wiskundige modellering en statistiese tegnieke
om drie onderwerpe op die veld van steroïedhormoon navorsing aan te spreek. Die
eerste is die hipokortisolisme wat in die Suid-Afrikaanse Angorabok gesien word. In
’n vergelykende analise is die konstruksie, parameterisering en validering van ’n model
wat die Δ4 and Δ5 padweë beskryf, beide in die skaap- en Angorabokspesies voltooi.
Met hierdie modelle word die kwessie van die identifisering van ’n moontlike teiken
vir behandeling aangespreek. Die tweede onderwerp is die steroïdogeniese aktiwiteit
in die lewer van die mens. Dit sluit in die konstruksie, parameterisering en validering
van ’n model wat die relatiewe omskakeling van klassieke androgene en 11-geöksideerde
androgene na hul onderskeie 5α of 5β reduksieprodukte in die menslike lewer beskryf.
Die model dui aan dat die 5β reduksie van beide die klassieke androgene en die 11-
geöksideerde androgene by fisiologiese bestendige toestand die voorkeurreaksie is. Die
derde en laaste onderwerp wat in hierdie studie bespreek word, is die steroïdogeniese ak-
tiwiteit in prostaatkanker C42B-selle. Die konstruksie, parameterisering en validering van
’n model wat die biosintese van die steroïedhormone in die C42B-kastrasie-weerstandige
prostaatkanker-sellyn beskryf, is ingesluit. Drie moontlike teikens vir die behandeling van
kastrasie-weerstandige prostaatkanker in C42B-selle word geïdentifiseer. Hierdie studie
beskryf ook die ontwikkeling van ’n addisionele Mathematica-pakket, IdentifiabilityAnalysis,
wat die proses van modelparameterisering en identifiseerbaarheidsanalise vergemaklik.





Steroid hormones play a key role in various processes in the body during all stages of
life and are classified into three main groups. Glucocorticoids regulate the immune sys-
tem and inflammatory responses, while mineralocorticoids maintain a healthy balance of
sodium and water in the body. The third group, sex steroids, regulate sexual develop-
ment and growth. These steroid hormones are all synthesised from a common precursor,
cholesterol, by an array of different enzymes. The cytochrome P450 enzymes and the hy-
droxysteroid dehydrogenase enzymes are the two main groups into which these enzymes
fall. Many of these enzymes are multi-functional and are expressed in different tissues
in the body. As such, these enzymes form intricate steroidogenic systems throughout
the body. Imbalances and defects in any of these steroidogenic pathways can lead to a
number of different diseases [70, 86, 102].
The main aim of this study is to demonstrate the application of analytical techniques
to construct, parameterise, and validate models of different steroidogenic systems. Com-
putational modelling of these complex systems has aided the study of steroid hormone
biosynthesis in various species. Such models include the model by Becker et al, which
was the first model describing testicular steroidogenesis [9]. Breen et al [15] used math-
ematical modelling of the intraovarian metabolic network in fish to study the effects of
endocrine active compounds in the environment on hormone synthesis. Murphy et al
[76] conducted a similar study by modelling the effects of endocrine disrupting chemi-
cals on two species of fish. Another study of the effects of endocrine disrupting com-
pounds on steroidogenesis was completed by Saito et al [93], who studied these effects
on the human endocrine system. Breen et al [13] also completed their own independent
study of these effects on human H295R cells with the use of computational modelling.
Nguyen et al [79–81] conducted extensive studies on steroid hormone synthesis in mam-
mals and constructed an accompanying model describing the dynamics of the Δ4 and the
Δ
5 steroidogenic pathways. Cook et al [22] modelled the oxidation of androsterone and
androstenedione in humans to study castration resistant prostate cancer. Another study
modelling hormone synthesis in humans was conducted by Selgrade and Schlosser [96, 97]
1
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who studied the nine stages of hormone synthesis in the ovaries. Chapter 2 contains an
in depth literature review of the examples of steroidogenic modelling mentioned above,
although the modelling of steroid hormone synthesis is not limited to these examples.
A comparative analysis of 17-OHPROG and A4 synthesis in ovine and
Angora goat models
Computational models have aided in the understanding of steroid hormone biosynthesis.
One question, which remains unanswered, is the dynamics of hypocortisolism in the South
African Angora goats. The mohair industry in South Africa suffers the loss of young An-
gora goats during cold spells as these animals are not able to produce sufficient levels of
cortisol to survive physiological stress. With South Africa being the leading producer of
mohair worldwide, this problem has great financial implications [74]. It was found that
the Angora goat has increased CYP17 activity, relative to 3βHSD activity [28]. These
two enzymes catalyse the reactions of the Δ4 and Δ5 pathways in steroid biosynthesis,
eventually leading to the synthesis of either aldosterone, cortisol or androstenedione [26–
28, 118]. A comparative study by Engelbrecht et al [28] between the Angora goat and
another wool producing, but more hardy livestock species, the Merino sheep, determined
that there is little difference in the synthesis of aldosterone between the animals, but a
greater difference in the synthesis of cortisol and androstenedione [26–28].
Due to the multi-functionality of the two enzymes of the Δ4 and Δ5 pathways, it is
difficult to pinpoint exactly how the increased CYP17 activity affects the flux of steroids
through the pathway. It is not known which of the two enzymes has more control over
the flux and the concentrations of the system, and where exactly in the pathway the most
control lies. The effect of a stress response on the flux through the pathways an how it
differs from the system without stress has also not been investigated. Once this is known
for the Angora goat and ovine species a comparison can be made to identify the origin
of hypocortisolism and finally some possible treatment target or strategy can be identified.
In chapter 4 we address these questions of hypocortisolism in the Angora goats with
the aid of computational modelling. The first aim is to construct and validate a model for
steroid hormone synthesis in the ovine species, which is used as a control model for steroid
biosynthesis. This model will describe the Δ4 and the Δ5 branches of the steroidogenic
pathway, leading to the synthesis of either cortisol or androstenedione. The first objective
of this aim is to parameterise the model with experimental transfection data. The second
objective is to validate the ovine model against experimental transfection data as well
as animal data from literature. The third objective is to validate this model against the
theoretical model published by Nguyen et al [81]. The second aim is to create a model
describing these same Δ4 and Δ5 branches of the pathway, but for the Angora goat.
2
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The first objective is to construct the Angora model by adapting the ovine model. The
second objective is to validate the Angora model against experimental transfection data
in literature. The third aim is to analyse and compare the dynamics of the ovine and the
Angora model. The objective is to conduct metabolic control analysis and steady state
analysis of the models. This will show how the multi-functional dynamics of the enzymes
of theΔ4 andΔ5 pathways lead to the hypocortisolism in the South African Angora goats.
Modelling the 5α and 5β reduction of 11-Ketotestosterone in the liver
Computational models can also aid in the process of understanding and describing the
dynamics of novel steroidogenic pathways. In recent years the role of 11-Ketotestosterone
has been proven as a potent androgen [87, 108]. Studies are also being undertaken to
determine the involvement of 11-oxygenated androgens in various hormone sensitive dis-
eases such as polycystic ovary syndrome, congenial adrenal hyperplasia, and castration
resistant prostate cancer [7, 77, 87]. The 11-oxygenated androgens are equipotent to
the classic androgens, however, these androgens have not yet been studied in the same
amount of detail as the classic androgens. As such there is still much to be learnt of their
dynamics, especially when pooled with the classic androgens. Both the classic androgens
and the 11-oxygenatated androgens can be converted to different products, depending
on which enzyme it binds to. In the liver, where the enzymes AKR1D1, SRD5A1, and
SRD5A2 are expressed, these androgens can be either 5α reduced by SRD5A1 or SRD5A2
or 5β reduced by AKR1D1. The 5α products are potent androgens, but the 5β products
are not. As these enzymes have different efficiencies for the different androgen substrates
and are present in the liver at different expression levels, it is difficult to predict how
much of each androgen substrate will be converted to potent 5α products or non-potent
the 5β products.
The main research aim of Chapter 5 is to predict ratios of these 5α and 5β products
of both the classic and 11-oxygenated androgens. The first objective is to construct and
parameteris a model of the AKR1D1, SRD5A1, and SRD5A2 enzyme kinetics in the
human liver is with experimental transfection data. The second objective is to include
the physiological expression levels of these enzymes in the model, whereafter the third
objective is to study the model simulations at steady state. We are able to determine the
relative conversion of testosterone and 11-Ketotestosterone to their respective 5α and 5β
reduction products in the liver of both men and women.
3
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Computational modelling of the intratumoral androgen metabolism in
castration resistant prostate cancer
Modelling of steroid hormone biosynthesis can also be used to identify possible treatment
targets for hormone sensitive diseases, such as castration resistant prostate cancer. This
type of cancer often emerges after the initial treatment of chemical or physical castra-
tion for prostate cancer fails. The pathway that is followed in the synthesis of potent
androgens in castration resistant prostate cancer is the 5αDione pathway. It has also
been found that the 11-oxygenated androgens can serve as substrates for this type of
cancer [7, 45, 98]. Similar to the systems mentioned above, the enzymes catalysing these
reactions are multi-functional. As such, with the classic androgens and 11-oxygenated
androgens pooled, these enzymes can convert androgens from either group into their re-
spective intermediates and products. Knowing how these enzymes interact when compet-
ing for the same substrates will aid in the search of novel treatment targets for castration
resistant prostate cancer.
In chapter 6 we aim to identify possible treatment targets for castration resistant
prostate cancer in C42B cancer cells with the aid of mathematical modelling. The first
objective is to construct a model that describes the combined dynamics of the 5αDione
and the 11-oxygenated androgen pathway in C42B cancer cells. The second objective
is to study the model at physiological steady state and the effects of inhibiting and
up-regulating the enzymes. We identify three possible treatment targets for castration
resistant prostate cancer in C42B cancer cells.
Chapter 3 is a review of analytical techniques and describes the development of a novel
Mathematica add-on package IdentifiabilityAnalysis. The functions of this package
have been used throughout this project to analyse experimental data and construct the
accompanying steroidogenic models. The use of the package is however not limited to
steroid hormone research. The package contains five functions which include fitting of
the user input data to a model described by ordinary differential equations, testing the
identifiability of newly determined parameter values, as well as creating profile likelihood
plots. The aim in creating this package was to simplify the process of model parame-
terisation and identifiability analysis, by minimising the amount of coding needed to be
completed by the user.
In summary, this study consists of two review chapters and three research chapters.
Chapter 2 is the first review chapter and gives a brief overview of mammalian steroid
hormones and a literature review of mathematical models of steroid biosynthesis in both
humans and other animals. Chapter 3, the second review chapter, is a summary of the
analytical methods used during data analysis and model construction. This chapter also
includes an outline of the IdentifiabilityAnalysis package. Chapter 4 is the first
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research chapter and contains the development of the models describing the Δ4 and Δ5
pathways in the ovine and Angora goat species. The second research chapter, chapter 5,
outlines the development of the model describing the 5α and 5β reduction of classic an-
drogens and 11-oxygenated androgens in the human liver. Chapter 6 is the final research
chapter in this study and includes the development of the model describing the androgen
metabolism in castration resistant prostate cancer C42B cells. This study is concluded
with a general discussion, Appendix A which contains the identifiability analysis results of




Literature review: steroid hormones
This chapter contains a brief overview of mammalian steroid hormones, the zonation of
adrenal cortex and diseases caused by any abnormalities or deficiencies in the steroido-
genic pathways. A literature review of mathematical models describing steroidogenesis
in various species is included. A review of two models in literature, relating to the work
done in this study, concludes this chapter.
2.1 Mammalian Steroid Hormones
Three classes of steroids are synthesised and secreted in mammals by the adrenal cortex;
the mineralocorticoids, the glucocorticoids and the gonadocorticoids [21, 102]. These
steroids have various physiological functions throughout the body [15]. Figure 2.1 shows
the partial steroidogenic pathway. Cholesterol, a steroid hormone precursor, is converted
into steroid hormones by the cytochrome P450 and hydroxysteroid dehydrogenase en-
zymes [69, 70, 79, 86, 102]. These steroid hormones are 3βHSD, CYP11A1, CYP11B1,
CYP11B2, CYP17, and CYP21 [21, 69, 70]. Cholesterol is converted to Pregnenolone
(PREG) by CYP11A1 whereafter either 3βHSD or CYP17 converts PREG to Proges-
terone (PROG) or 17-hydroxypregnenolone (17-OHPREG) respectively. CYP17 can also
convert 17-OHPREG to dehydroepiandrosterone (DHEA) as well as convert PROG to
17-hydroxyprogesterone (17-OHPROG) and in turn convert 17-OHPROG to androstene-
dione (A4). The conversion of 17-OHPREG to DHEA by the lyase activity of the CYP17
enzyme is more effective than that of the conversion of 17-OHPROG to A4, specifi-
cally in the human, primate, ovine and bovine species. In these species A4 is mainly
produced from DHEA. CYP17 also synthesises 16-hydroxyprogesterone (16-OHPROG)
from PROG along with 17-OHPROG. The synthesis of 16-OHPROG is more prominent
in humans and primates, while synthesis of 16-OHPROG in goats and sheep are present,
but minimal [21, 47, 69, 70, 79, 86, 110]. The hormones 17-OHPREG and DHEA can be
converted to 17-OHPROG and A4 by 3βHSD respectively [21]. A4 is then converted to
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Testosterone (T) by 17βHSD [102]. CYP21 can then convert PROG and 17-OHPROG
to deoxycorticosterone (DOC) and deoxycortisol (DOCL) respectively. DOC and DOCL
are in turn converted to corticosterone (CORT) and cortisol by CYP11B1 respectively.
CYP11B2 then finally converts CORT to 18-hydroxycorticosterone and that in turn to
aldosterone [70, 86, 102]. In the species of human, sheep, goat and cattle, the Δ5 pathway
is preferred for the synthesis of A4 [21, 70, 103, 111]. In both the porcine and rodent
species A4 is synthesised via either the Δ4 or Δ5 pathways, the Δ4 pathway is preferred

























2.1. Mammalian Steroid Hormones
Steroid hormones are synthesised on demand as cells do not store these hormones. The
levels of steroid substrates and the steroidogenic enzyme activity regulate steroid hormone
biosynthesis [91].
2.1.1 Zonation of the adrenal cortex
The adrenal cortex consists of three zones; the outer zona glomerulosa (ZG), the inner
zona fasciculata (ZF), and the zona reticularis (ZR). The ZF makes up the majority of
the adrenal cortex (about 75%), while the ZG only makes up about 15% of the adrenal
cortex, with the remaining 10% consisting of the ZR. Not all steroidogenic enzymes are
expressed in each of the three zones and as a result the synthesis of steroid hormones are
zone specific. [21, 70, 86, 102].
2.1.2 Diseases
There are various diseases caused by imbalances in steroid hormone biosynthesis.
Congenial adrenal hyperplasia (CAH) can be caused by a deficiency in either 3βHSD
or CYP17, however CYP21A2 deficiency is most common [84, 85, 102]. This leads
to decreased production of cortisol, aldosterone, PROG, androgens, and estrogens
[69, 70, 84, 99, 102]. Disruption in normal 3βHSD activity can have a critical effect
on physiological processes, This is caused by disruptions in the normal production of
the steroid hormones [70, 72, 84, 99]. Polycystic ovary syndrome (PCOS) leads to
increased androgen secretion, caused by an irregularity in the steroidogenic pathway
[69, 90, 116]. Cushing Syndrome is caused by increased levels of glucocorticoids in
the system. Symptoms include obesity, acne, hirsutism in female patients, depression,
lethargy, insomnia, and amongst others, hypertension [102]. Patients can also suffer from
glucocorticoid deficiency. This includes Addison Disease, Autoimmune Adrenalitis and
Hypoadrenalism [102]. Hormone dependent cancer, such as breast cancer and prostate
cancer, are also influenced by the dynamics of steroid hormone biosynthesis [1, 7, 71].
A comprehensive understanding of steroid biosynthesis is fundamental for identifying
possible branches in the pathway to target for treatment of endocrinological disorders to
ensure proper steroid synthesis [21, 65, 79]. Imbalances in the steroidogeneic pathway can
have a negative effect on normal physiological functions. It is however not entirely clear
how these imbalances influence steroid biosynthesis exactly [38]. Many studies have been
conducted with the aim of understanding the differences in flux through the pathways
in different species [21, 31, 79, 80]. Steroidogenic models promote the understanding of
biochemical processes and responses to stimuli and could aid in identifying predictive
biomarkers. If properly constructed such a model could simulate the therapeutic or
negative effects that compounds may have on hormone biosynthesis [15, 38].
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2.2 Computational models of steroid biosynthesis
To gain insight into steroid biosynthesis, studying the differences in hormone production
in different species can be beneficial. Differences and similarities in enzymatic activity
between species can grant insight into steroid biosynthesis at a biochemical and
physiological level [21, 27, 28]. Mathematical models that accompany the experimental
studies aid the process of understanding the flux of steroids through biochemical
pathways [15, 79–82, 125]. It is often challenging to replicate the steroidogenic pathways
experimentally, especially more complicated pathways where the inhibition of one
branch may affect the other parts of the pathway. Another limitation is the financial
implications with the completion of a large number of experimental procedures to gain
understanding of steroid biosynthesis [22]. Mathematical models are not subject to such
limitations [22, 82]. With mathematical models existing knowledge can be combined,
making it easier to identify gaps in the current research [22]. Although in silico analysis
of a system does not necessarily eliminate the need for experimental work, it can aid in
the process of experimental design [22].
In 1980 Becker et al [9] created the first mathematical model that describes testicular
steroidogenesis. The model was created with two goals in mind: to predict the
secretion rates of steroids during biosynthesis, and to test the validity of assump-
tions used in studies of testicular T synthesis. This model is specific to rabbits and
rats. Model validation consisted of comparing predicted steroid secretion rates with
those of in vitro perfused control testes. The predominant pathway for T synthesis
from the PREG precursor in rabbit and rats testes was also determined through analyses.
Breen [15] created a steady state mechanistic model of the intraovarian metabolic
network. The model describes the synthesis of T and estradiol (E2) as well as the
influence of endocrine active compounds of therapeutic or environmental nature on the
hormone synthesis. The dose-response behaviour of endocrine active compounds were
studied and the model was developed to show the biochemical response induced by
perturbations at a physiological level. The model was parameterised for the Cyprinidae
species (fathead minnow). The ecological significance of this small fish makes it a good
animal model. In addition the Cyprinidae species is a large family of fish that has been
studied in great detail. Much is know about culturing of the fish and its life cycle, as well
as how to manipulate its reproductive cycle. Its 4-5 month life cycle and sufficient ovary
tissue volume at maturation that can be used for steroidogenic assays also contribute to
its appeal as an animal model. The design of the model includes the metabolic pathway
and the transport pathway. It describes the enzyme kinetics in both the culture medium
and the ovary tissue where the transport pathway includes the uptake of substrate
(cholesterol) and the secretion of products (A4, estrone, T and E2). The metabolic
9
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pathway includes the conversion of substrate to products and the enzyme inhibition by
Fadrozone, an endocrine-active chemical (EAC) which results in competitive enzyme
inhibition. Parameter values were determined by a least squares fitting of the model
to mean concentration values from replicate studies. Two parameter values were taken
from literature while the remaining 11 parameters were fitted for. Vmax and Km values
for each branch in the pathway were fitted for as a single rate constant. A sensitivity
analysis of the 11 parameters showed which parameters resulted in the largest changes
in model output induced by small changes in the parameter values. The model is a good
example of the use of a steroidogenic model to predict in vitro assay results.
EACs can alter normal human endocrine function. Breen et al [13] developed a
computational model describing the effect of EACs on steroidogenesis. The model was
parameterised with in vitro data of steroidogenesis in H295R cells. The model includes
the culture medium and the H295R cells as two compartments. The transport pathway
of cholesterol uptake forms part of the model dynamics as well as the metabolic pathways
of hormone metabolism and secretion. The metabolism of the following hormones are
included: PREG, 17-OHPREG, DHEA, PROG, 17-OHPROG, A4, T, DOC, CORT,
aldosterone, DOCL, cortisol, estrone (E1), and E2. The enzyme inhibitory effects of
metyrapone (MET) also forms part of the model dynamics. MET is and EAC that
inhibits the enzyme CYP11B1. Sensitivity analysis showed that the 17-OHPREG
pathway is preferred over the PROG pathway for the synthesis of CORT [14]. This
model was later expanded by Breen et al to include cell proliferation and the synthesis
of oxysterols.
Murphy et al [76] developed a model that describes the synthesis of vitellogenin in mature
female sciaenid fish. Two model-organisms of the Scianidae family is used, spotted
seatrout (Cynoscion nebulosus) and Atlantic croaker (Micropogonias undulatus). Both
of these animals are well-established models for studying reproductive endocrinology and
endocrine toxicity. Vitellogenin is a yolk precursor protein and proper synthesis thereof
during the larval fish life stage is crucial. Chemical compounds and environmental factors
can alter the reproduction of fish by disrupting endocrine function. High concentrations
of trace elements, like cadmium, can hinder the processes of gonadotropin regulation
and steroidogenesis. Gonadotropin and vitellogenin are biomarkers for disruptions in
endocrine and reproductive function. The model describes the effect of two endocrine
disrupting chemicals (EDCs) on vitellogenin synthesis in fish. The model consists of
eight ODEs showing vitellogenin synthesis in a mature female fish over a period of six
months with hourly introduction of gonadotropin. The ODEs correspond to the rate of
change of the following metabolites: T, steroid binding protein (SBP), SBP bound to
T, E2, SBP bound to E2, estrogen receptor (ER), ER bound to E2, and vitellogenin.
The model is used to simulate the disruptive effects of EDCs on steroidogenesis and
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vitellogenisis and is compared to field data.
Saito et al [93] created a model, describing steroidogenesis in humans, that allowed them
to study the effects of various endocrine disrupting compounds on human endocrine
function. Human adrenocortical carcinoma NCI-H295R cells were used for collecting
in vitro experimental data of steroid hormone synthesis. These results were used to
parameterise the mathematical model, along with parameter values taken form literature.
The model includes four important processes: cell proliferation, intracellular cholesterol
translocation, the diffusional transport of hormones, and the metabolic pathways of
adrenal hormone synthesis. This comprehensive model includes 14 steroids in the
steroidogenic pathway (starting with cholesterol), metabolised by nine enzymes. Results
of sensitivity analysis suggested that the enzyme 3βHSD has the greatest influence on
steroid biosynthesis. Saito et al also monitored which enzymes were most affected by
adrenal toxic substances (11 compounds were tested). Adrenal toxicity is an unavoidable
concern during the drug development process.
Selgrade and Schlosser [96, 97] developed a model describing the synthesis of the ovarian
hormones E2, PROG, and inhibin, and the gonadotropin hormones, luteinizing hormone
and follicle stimulating hormone. These five hormones play a role in the regulation and
maintenance of a normal menstrual cycle. The model was created with the goal in mind
to test he effects of exogenous compounds on the human menstrual cycle, therefore a
model of a normal menstrual cycle was developed. The model is a system of linear
ODEs describing the blood levels of these hormones during the nine stages of hormone
synthesis in the ovaries. Model validation was done by comparing the model to data in
literature of women with normal menstrual cycles.
The following work by Cook et al [22] and Nguyen et al [79, 81] relates most to the work
shown in this study.
Cook et al [22] developed a model of the oxidation of androsterone to androstanedione
in humans. The model was developed to aid in the understanding of androgen synthesis
and the progression of castration resistant prostate cancer (CRPC). Prostate cancer cell
proliferation is triggered by the androgens T and dihydrotestosterone (DHT). Treatment
is administered in the form of surgical or chemical castration to reduce the levels of
circulating T. DHT can be synthesised via three pathways, the frontdoor pathway and
two backdoor pathways. DHT is synthesised from T via the frontdoor pathway, however,
the two backdoor pathways do not require T as an intermediate metabolite in the
production of DHT. This model only describes one branch in the pathway. The model
was parameterised with values from from literature and with experimental data.
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These classic androgen pathways, as discussed in the above mentioned study by Cook
et al is reparameterised for C42B CRPC cells in chapter 6. The dynamics of the
11-oxygenated androgen pathway is also included to consider the effects of both the
classic androgens and the 11-oxygenated androgens on the dynamics of CRPC in C42B
cells.
Nguyen [79, 81] investigated the effect that a change in the PREG supply can have on
the synthesis of steroid hormones. The paradoxical increase of E2 in rhesus monkey and
sheep with inhibition of 3βHSD is studied. The synthesis of androgens and estrogens in
the species human, primate, ovine and bovine is studied with a mathematical model.
The model describes minimal conversion of 17-OHPROG to A4 with the majority of A4
being synthesised via the Δ5 pathway. The model includes a constant supply of PREG
and constant secretion of all steroid intermediates and products, including PREG. The
steroid secretion rates are dependent on the steroid concentration and a coefficient value,
used for all steroids in the pathway. The maximum reaction rates for an enzyme is
assumed to be the same for all reactions catalysed by the enzyme. With this model it is
shown that the three main influences on the rate of steroid production are the availability
of substrate, the rate at which steroid hormones are secreted, as well as the enzyme
activities. The specific changes in the rate of steroid biosynthesis caused by these three
influences is dependent on the biochemical nature of the enzyme reactions. The model
includes the competitive inhibition of the different substrates that are metabolised by
the same enzymes. The effect that varying enzyme activities and substrate levels can
have on the synthesis of the final products (estrogens and androgens) is shown. This
model was constructed with parameter values taken from various studies in literature.
It is a theoretical model which describes the dynamics of the Δ4 and Δ5 pathways in
general in the human, non-human primate, ovine and bovine species. This model also
does not take into account the synthesis of 16-OHPROG, which is not synthesised in
negligible levels in human and non-human primate species [110].
Steroidogenic enzymes are compartmentalised and many are membrane bound. Both
CYP17 and 3βHSD are found in the endoplasmic reticulum, however 3βHSD is also
found in the mitochondria. As steroids have high intracellular diffusion coefficients
the compartmentalisation should not have a great effect on steroid synthesis. Nguyen
investigated the effect that the compartmentalisation of enzymes could have on the rate
of steroid synthesis [80]. A mathematical model of the reaction-diffusion kinetics of
CYP17 and 3βHSD was used. It was determined that the rate of steroid synthesis is
not greatly influenced by the spatial separation of the enzymes within the endoplasmic
reticulum. The rate of steroid synthesis is however influenced by the separation of
enzymes in different cells. When the enzymes CYP17 and 3βHSD are in different cells,
an increased distance between the cells leads to decreased steroid production. This
12
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separation of CYP17 and 3βHSD increases the ratio between the Δ5 pathway and the
Δ
4 pathway when CYP17 and the PREG supply are in the same cell. It was determined
that no compartmentalisation of any kind had any effect on the qualitative result of
steroid synthesis with variation in enzyme activity or PREG supply. Although the
absolute concentrations of the synthesised steroids changed, the levels of the steroids
relative to each other remained fairly similar [80].
This general model for steroidogenesis, as developed by Nguyen et al [81], is adapted and
parameterised for the ovine species as well as the South African Angora goat in chapter 4.
The South African Angora goat is an example of an experimental system showing the
effects of altered enzyme activity levels on steroid biosynthesis. The Angora goat suffers
from reduced cortisol production (hypocortisolism) [27, 28, 118]. The Boer goat and
Merino sheep are considered to be good control models as they do not experience this
reduced cortisol production seen in the Angora goats [27, 28].
Many studies have been conducted toward understand the hypocortisolism in Angora
goats [27, 28, 39, 48, 103, 104, 106, 118, 123]. It was found that both CYP17 and 3βHSD
contribute to the hypocortisolism seen in the Angora goats. Identifying the cause of the
hypocortisolism proved to be complicated as there is more than one factor contributing
to the imbalances in the steroidogenesis [27, 28, 38, 39].
Whether cortisol is synthesised via the Δ4 or Δ5 pathway is determined by the expression
levels of 3βHSD and CYP17 relative to each other [10, 21, 111]. CYP17 and 3βHSD
compete for the same steroid substrates (PREG and 17-OHPREG). The relative
expression of these two enzymes, their substrate specificities as well as their activities all
influence the flux of steroid hormones through the pathway [10, 21, 38, 70, 79, 81, 111]. A
lower expression of CYP17 relative to 3βHSD will favour the synthesis of glucocorticoids
while a higher expression of CYP17 relative to 3βHSD will favour the synthesis of
androgens [10, 21]. The 3βHSD enzyme’s activity is subject to product inhibition [79].
The reactions of 3βHSD are reversible while cytochrome P450 reactions are irreversible
[70]. Due to this complexity it is challenging to predict the effect that flux changes
through the branches of the pathway might have on the synthesis of steroids [79–81].
These steroidogenic processes are complex and the experiments are expensive. The use
of models that accurately describe the hormone biosynthesis for both a control species
and the steroid deficient species could help circumvent these limitations.
Dr R. Conradie (at Stellenbosch University, unpublished) created a computational model
of the Δ5 steroidogenic reactions of the CYP17 enzyme. The model showed the change
in concentrations of PREG, 17-OHPREG and DHEA over time.
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Van Schalkwyk [119] expanded on this model by including the Δ4 reactions of CYP17 as
well as the reactions catalysed by 3βHSD. Van Schalkwyk studied the kinetics of both
CYP17 and 3βHSD and the effects that they have on each other. A computational model
was constructed of the partial steroidogenic pathway consisting of these two enzymes.
The model describes the change in concentration of the substrates, intermediates and
products of the pathway over time. Michaelis-Menten equations with product inhibition
were used to describe the enzyme kinetics. The rate equations included the enzymes
CYP17 and 3βHSD competing for the same substrates and intermediates. These rate
equations form the ordinary differential equations used to construct the model which was
used to estimate the kinetic parameters. The parameters for the reactions catalysed by
CYP17 and 3βHSD were estimated separately for the two enzymes. Progress curve data
for the conversion of PREG to the respective intermediated and products by CYP17 and
3βHSD were used. Initial rate analysis was used to normalise these experiments. The
parameter values subsequently obtained were used to construct the model. This model
describes the competitive nature of the two enzymes as well as the steroid flux through
the pathway. Although the model was validated, no identifiability analyses were done on
the parameter estimations. The following chapter is a review of the analytical methods




Literature review: analytical and
mathematical methods
This chapter is an overview of some of the analytical methods used during the con-
struction of ordinary differential equation (ODE) based models. The aim of many
scientific studies is to solve some form of the inverse problem. The inverse problem
is to determine the structure and functional dynamics of a system from experimental
observations. Mathematical model selection based on the known information about the
system is the first step towards solving the problem. Experimental design (subject to
resource availability, and financial and time constraints) is the next important step. As
the number of experiments that can be completed is often limited, much importance
lies in designing the experiments so that the results will contain as much of the needed
information as possible. The experiments are then conducted and the results analysed,
whereafter the final step in solving the inverse problem is completing identifiability
analysis [19, 30, 55, 126].
Mathematical models are used for analysing data, drawing conclusions from data and
predicting future outcomes based on current data [83, 126]. Regression analysis can
help with the development of accurate models, and is used for studying the relationship
between variables, describing data, predicting outcomes and estimating parameter
values. This statistical technique is used in multiple fields of research, including the field
of biochemistry for the study of enzyme catalytic reactions [73, 126].
For detailed mechanistic models of enzyme catalytic reactions, the process of data fitting
can be divided into the following steps: the first step is to determine a suitable mechanism
that describes the enzyme kinetics. The model is then fitted to the experimental data by
means of linear or non-linear regression [17, 18, 55, 126]. An objective function is used
to minimise the difference between the observed data and the model fit. The method by
which the parameter values are solved for numerically needs to be specified. Thereafter




the data. Part of this validation step is identifiability analysis. If the model is shown
not to be appropriate for the data, this process is repeated [58, 61].
This chapter serves as an overview of some of the methods and techniques available that
can be used during each of the steps mentioned above. Model selection is discussed
first, followed by linear and nonlinear regression methods. Identifiability analysis of
parameters, and methods of determining their confidence intervals are discussed, and
finally metabolic control analysis is briefly described.
3.1 Model selection
There are various classic mathematical methods that have been used for decades
to develop models for biological systems. These include ordinary regression models,
generalised linear and nonlinear regression models and growth curve models [83]. The
model type as well as the number of parameters will determine which method is to be
used [5].
Model selection should not only depend on the dynamics of the system, but the type
and quantity of the available data should also be considered. The enzyme kinetics
of the biological systems addressed in this study can be described with reversible or
irreversible Michaelis-Menten kinetics, and in some cases with product inhibition. For
the majority of the analyses, the quantity of the available data were sufficient and the
model was constructed with Michaelis-Menten equations. There were however instances
where the available data was not enough to fully parameterise parts of a system. In
these cases mass action kinetics were used to describe those parts of the system. The
models used in this study therefore consists either entirely of Michaelis-Menten kinetics
or a combination of Michaelis-Menten kinetics and mass action kinetics.
3.1.1 Michaelis-Menten kinetics
Victor Henri was the first to attempt to describe enzyme kinetics with the aid of an
equation. He hypothesised that the rate of an enzymatic reaction is proportional to the
concentration of the enzyme-substrate complex. He was however not able to prove this
experimentally [42, 56]. Michaelis and Menten were able to prove Henri’s hypothesis
experimentally and in the process the Michaelis-Menten equation was derived, which to
this day is still used to describe enzyme kinetics [56, 68]. In 1925 Briggs and Haldane
published the derivation of the Michaelis-Menten equation [16]. In its simplest form, the







where v is the rate of a reaction, Vmax is the maximal rate, Km is the dissociation
constant (also referred to as the half saturation constant), and [S] represents the
substrate concentration [68, 95]. The Michaelis-Menten equation can be extended and
be made reversible to include the effects of product (feedback) inhibition, competitive
inhibition, uncompetitive inhibition, noncompetitive inhibition, irreversible inhibition,
and allosteric regulation [95].
3.1.2 Hill equation
The Hill equation, derived by Archibald Hill in 1910, is a variation of the Michaelis-






where n is the Hill coefficient which is number of ligand binding sites per molecule of
enzyme, Kn is the constant including the effects of the Km and the interaction factors
of the allosteric binding sites, and [L] is the ligand concentration [37, 95].
3.1.3 First order kinetics or Mass action kinetics
In the case where the concentration of the substrate is much smaller than the dissociation
constant ([S] Km), the linear relationship between the enzyme rate and the substrate





where k is a first-order rate constant. The use of this equation is beneficial when little




per reaction is reduced to only one unknown [95].
When it comes to fitting the model to data, there are different methods to choose from.
Linear and nonlinear regression can be completed with the use of various methods,
depending on the requirements of the system [5]. Details of these methods and their
applicability will be discussed next.
3.2 Linear regression
Linear regression is used for the analysis of data that describes the relationship between
variables in a linear pattern. The most basic example of such a model, where only one
independent variable is involved, is a simple linear regression model [17, 73].
y = β0 + β1x+ ε
where the dependent variable or response variable, y, is the observed data, x is the
independent predictor or regressor variable and β0 and β1 are two parameters, also
called regression coefficients [17, 73]. The statistical error in the data is represented by
ε. It is assumed that these errors are not correlated, have a mean of zero (and unknown
variance σ2). Multiple linear regression models, as shown below, include more regressor
variables and parameters [8, 73].
y = β0 + β1x1 + β2x2 + · · ·+ βkxk + ε
Models in which the dependent variable is a nonlinear function of the independent
variable(s) can be parameterised with linear regression as long as the dependent variable
is a linear function of the parameters [17, 73, 92].
3.3 Nonlinear regression




yi = f(xi,θ) + εi, i = 1, 2, ... , n
where yi is the measured experimental values and εi is normally distributed random
error with mean zero and variance σ2 [18, 73]. The function f is called the expectation
function with xi a vector of independent variables and θ a p × 1 vector of parameters
[73]. At least one of the derivatives of the function f , with respect to the parameters,
depends on at least one of the parameters [73].
3.4 Regression methods
Two often used methods for data fitting are the least squares method and the maximum
likelihood method [17]. They are intuitive and computationally easy to implement [83].
3.4.1 Least squares estimation method
The least squares method is predominantly used when determining the goodness of fit of
linear as well as nonlinear models [17, 18, 36, 92]. The linear and nonlinear least squares
methods are used for parameterising models that are either linear or nonlinear in the
parameters [36]. The sum of the squared residual values SSR between the measured data
and the model fit are minimised. This method returns the parameter value estimates







where SSR(θ̂) is the sum of the squared residual values, N is the number of measured
data points y(ti) and ŷ(ti, θ̂) are the fitted data points [58, 73].











where the measured data points ŷ(ti, θ̂) can be expressed as a linear or nonlinear function
f(xi, θ̂) of the variables xi and parameters θ. θ̂ is the set of parameters that is returned
as the best fit [73].
3.4.1.1 Weighted least squares fitting and Chi-square
Weighting of experimental data points during the data fitting process is crucial for
ensuring accurate model regression [56, 73]. The sum squared residual values between the
model fit and the experimental data can be weighted to an average standard deviation
value or each of these sum squared residual values can be weighted individually to the
variance of the experimental data points [25, 36, 56, 73]. Weighting the sum squared
residual value for each of the experimental data points to the variance of that point







The χ2 values have a Chi-square distribution [23]. These values are scalar goodness of
fit measurements. The above χ2 is known as the objective function during regression
fitting [36].
3.4.2 Maximum likelihood method
The maximum likelihood can be calculated by minimising the least squares estimates if
the observational noise or error is normally distributed [8, 30, 61]. Both the maximum
likelihood and the least squares methods try to determine which set of parameter values
will ensure a fitting of the mathematical model closest to the experimental data [20].
Linear and nonlinear least squares methods are similar to the maximum likelihood
method when the residual values are normally distributed. Under these conditions
minimising the weighted least squares residuals is similar to finding the maximum
likelihood estimation of the parameters [67, 126].
The maximum likelihood method is mainly used for statistical models where the mean
and the variance are not known and need to be estimated and is thus set as parameters




all possible parameter estimations to find the solution that is most likely to have resulted
in the observed data. The set of parameter values that maximises the likelihood of the
occurrence of the observed data are returned. Log likelihood can also be used instead
of likelihood as the natural logarithm does not affect the maximising of the likelihood
[23, 50]. The likelihood function or the log of the likelihood function is differentiated
and these partial derivatives are set equal to zero. The Newton-Raphson method or
gradient methods can then be used to find the optimal set of parameter values. The
Newton-Raphson method might be preferred as it may converge faster than the gradient
methods [23]. These methods and other regression algorithms are discussed in more
detail below.
3.4.3 Regression algorithms
Least squares methods minimise the sum squared residual value between the model and
the experimental data by iteratively changing the parameter values [18, 36, 62]. There
are different ways of finding this parameter set. The search methods simply searches for
the optimal parameter set over a specified parameter space [18, 25]. The computational
time needed can become long when working with more than a few parameters [18].
Gradient methods iterate over the error space and uses the gradient of the error space
to find the direction in which the minimum lies. With these methods the optimal
parameters are found faster than with the search methods [18, 25]. Gradient methods
include Newton’s method, Marquardt’s method and the Fletcher-Powell method [18].
Most gradient methods are fast, but are hindered by noisy data and can lead to biased
parameter estimations and local minima [18].
3.4.3.1 Gauss-Newton
This method starts with an initial estimate for the parameter values θ̂j and then
uses Taylor series expansions and ordinary least squares estimation to alter the initial
parameter estimation. Good initial estimates of the parameter values will ensure that an
accurate solution is found faster [8, 36, 92]. A new estimated value θ̂j+1 for the parameter
is returned. This process is repeated until the changes in the objective function, equation







|θ̂(j+1) − θ̂(j)| (3.2)
The partial derivative, equation 3.3, is a gradient vector and can be used to determine in




Overstepping the optimal parameter estimation can be avoided by using the modified
Gauss-Newton algorithm. The change in step length i.e. the change from θ̂(j) to θ̂(j+1)
is modified with a specific value α. There are different methods of choosing α, one of
which is step halving, where α is set to 1
2
[8, 92].
This method is not guaranteed to return the optimal parameter estimations. The success
of the Gauss-Newton method depends strongly on the shape of the solution space close
to the model solution and how close the initial choice is to the true parameter values
[92].
3.4.3.2 Nelder-Mead
This method is categorised as a direct search method. It reduces the size of a simplex to
find the coordinates of a minimum in a solution space. A simplex is an N dimensional
triangle that represents the estimates of N parameters. With each iteration the largest
vertex of the simplex is replaced by a smaller vertex until a minimum solution is found [78].
3.4.3.3 Steepest Descent
During regression fitting this method changes the parameter values in the opposite
direction of the objective function’s gradient i.e. the parameter values are changed in the
downhill direction [36]. This method works well when the objective function is simple.
The steepest descent method works fast initially, but then slows down and can take
long to converge. This method can be useful when starting parameter optimisation with





This method is used for finding solutions for nonlinear least squares problems [36].
This is a combination of the steepest descent (or gradient descent) and Gauss-Newton
methods [5, 36]. The Levenberg-Marquardt method behaves like the Gauss-Newton
method when the parameter values are near their optimal solutions, and behaves like the
steepest descent method as the parameter values are farther from their optimal solutions
[36].
3.4.3.5 Newton-Raphson
Also simply called Newton’s method is very similar to the Gauss-Newton method, but
with the addition of the use of second partial derivatives 3.4 i.e. the Hessian matrix.
This method works only if the elements of the Hessian matrix are positive thus ensuring





This method is similar to the Newton-Raphson method that uses the Hessian matrix.
For this method the Hessian is replaced by a positive approximation (Hj) of the Hessian.
(Hj) is iteratively computed. Second order partial derivatives are no longer used [41].
3.4.3.7 Derivative free methods
These methods include the Secant method, which is similar to the Gauss-Newton method
apart from the derivative that are numerically calculated from past iterations [101].
3.4.3.8 Possible issues
Failing to converge might suggest that there is little variance in the sum of the squared
residual values near the minimum i.e. the solution space is flat. Starting the fitting
process with more accurate initial estimates of the parameter values might solve this
problem [92]. An overly complex model with simple data can also fail to converge.





Levenberg-Marquardt is a local search method that might not return the global minimum
as the optimal set of parameter solutions. Global search methods converge slowly once
near a global minimum. A good strategy is to use a global search method to find an
initial estimation for the parameter values whereafter a local search method is used to
find the optimal global minimum values for the parameters [5].
3.5 Identifiability analysis
Model parameters are considered identifiable if given a model describing the kinetics of a
system and a set of experimental data, the parameter values can be uniquely determined
[55]. If parameters are identifiable it is possible to determine the parameter values of a
model with the use of a specified set of initial concentrations and operating conditions
while the fitted model accurately describes a specific set of experimental data [127].
Once the model has been fitted to experimental data, weighted to the variance, a set of
parameter estimations are returned. Now one needs to test the identifiability of these pa-
rameter estimations. The goal of model fitting to data is not only to estimate parameter
values, but to determine parameter estimations that are accurate and identifiable. To
test the identifiability of parameter values is a popular method of determining parameter
value accuracy [59, 64]. There are different methods of verifying parameter identifiability.
3.5.1 Structural and practical non-identifiability
The non-identifiability of parameters can be classified as either practical or structural
non-identifiability. Substrate concentrations that do not fully saturate the enzyme
during the experimental procedure can lead to practical non-identifiability. The use
of an insufficient number of experiments, that describes the enzyme kinetics properly,
can also lead to practical non-identifiability. Structural non-identifiability occurs when
all the enzyme kinetics cannot be recreated experimentally, for example when it is not
possible to obtain data for all the intermediate substrate and product concentrations
in a enzyme pathway with multiple branches. Structural non-identifiability is also seen
when experimental data is fitted to a model that does not correctly describe the enzyme
kinetics [89]. An improvement in the quality or an increase in the quantity of data used





3.5.2 Identifiability analysis and experimental design
Due to time and financial constraints it is not always possible to conduct the full
number of experiments needed to construct a model and fully parameterise it. The
structure of the model sometimes does not allow for all the parameters to be estimated
experimentally. Insufficient information about the system, the complexity of the system
as well as the lack of observable data can also contribute to the difficulties of parameter
identifiability [34, 58, 59, 127].
The model structure, model parameterisation and experimental design can influence
parameter estimation and identifiability [30, 59, 127]. Computer simulations of the
system dynamics prior to conducting experiments can prevent the occurrence of practical
non-identifiability [30, 64]. There is a distinct link between parameter identifiability
and experimental design. An increase in the number of experiments and the variety
of experimental conditions will likely increase the number of identifiable parameter
estimations [64, 127].
Identifiable parameters are constrained within upper and lower bound confidence
intervals, therefore identifiability analysis and the calculation of confidence intervals are
closely linked.
3.6 Confidence intervals
When analysing experimental data with a model, much importance lies in calculating
confidence intervals for the optimised parameter values [3, 4]. The width of confidence
intervals are an indication of the goodness of fit of the model to the data. Wider
confidence intervals are an indication of poor parameter estimations where narrow
confidence intervals are an indication of a better approximation of the true parameter
values [4, 5, 59, 62, 73]. The confidence level (α) used when calculating the confidence
intervals represents the probability (100 ∗ (1 − α)%) that an estimated parameter value
will fall within the confidence interval. Therefore the choice in confidence level also needs
to be considered when evaluating a parameter value’s goodness of fit [62, 73]. Sample
size can also influence the width of the confidence intervals and larger sample sizes result
in narrower confidence intervals [4, 35]. There are two types of confidence intervals:





3.6.1 Asymptotic confidence intervals
Asymptotic confidence intervals can also be calculated with use of the Fisher infor-
mation matrix [30, 121]. These confidence intervals are most accurate if there is little
measurement noise and if the amount of data is large in comparison to the number of
parameters [89, 121]. These confidence intervals are accurate when the data is linearly
dependent on the parameters [89].








= Y T (θ)Y (θ)
where Y (θ) is the vector of residual values between the experimental data and the fitted
model values [5, 59]. With this vector of residual values the Jacobian matrix can be





J is the N × p matrix of partial derivatives, called the Jacobian matrix, with N
number of observations or measurements and p number of parameters [5, 59, 92].
The Jacobian matrix consists of derivatives of the residual vector with respect to
the parameters [29, 36, 53]. The Jacobian matrix can also be seen as the sensitivity
matrix [5, 53]. The Jacobian matrix is an indication of the local sensitivity of the
fitting function to changes in the parameters [36, 53]. The parameters are only
normally distributed if the errors in the data are normally distributed and if the model
is a linear function in the parameters and variables [2, 73]. If these conditions are
satisfied, the confidence intervals can be calculated with the use of Student’s t statistic [2].
Analytical methods of calculating the Jacobian matrix render an accurate result. This
method of calculating the Jacobian is not always feasible for large datasets or models of
nonlinear form as the sensitivity of the model is considered at each individual datapoint.
This method works well for small models, but can be computationally complex and time
consuming for larger models. Numerical methods of calculating the Jacobian matrix is






A more feasible approach for calculating the Jacobian when working with large scale
problems is the use of divided differences, also called finite differences or forward
differences [5, 29, 36, 49]. Considering the sensitivity of the model fit in terms of datasets






Y (θ + ∂θj)− Y (θ)
∂θj
where ∂θj is a small perturbation in the jth parameter [5, 29, 36].
The perturbation size can influence the accuracy of the this method [29, 49, 54]. A
relatively small perturbation size is needed for the calculation of the derivative values
[49]. A perturbation size of between 10−3 and 10−7 return good estimations of the
derivative values [29, 54] with the optimal perturbation size being between 10−4 and
10−6 [54, 66]. The symbolic manipulation tools of programs such as Mathematica can
also be used to calculate the Jacobian matrix, but due to the computational resources
needed when working with large models, this approach is better when working with
small models [49].
3.6.1.3 Error variance
Along with the Jacobian matrix, the error variance is also needed in the process
of calculating asymptotic confidence intervals. During least squares fitting, residual
values are calculated and minimised. It is assumed that these residual values (ri) are

















for N number of data measurements and m number of variables [73, 92].
The mean squared measurement error is calculated after the optimal set of parameter




where p is the number of parameters. The variance and Jacobian matrix is needed
to calculate the covariance matrix, which is then needed for calculating asymptotic
confidence intervals [73].
3.6.1.4 Covariance matrix
The covariance matrix of the parameter estimations is shown below [62, 73, 92]:
Cov = σ̂2(JTJ)−1
Cov = σ̂2(H)−1
where H is the Hessian matrix, a matrix of second partial derivatives [5, 18].
The diagonal elements of Cov is the variance in the parameters [2, 62, 73] and the other
elements are the covariance between the parameters [73]. The square root of Covjj is
the standard error of the parameter, θj, if the parameter estimation adheres to Gaussian
(normal) distribution [2]. The inverse of Covjj can therefore be used as the weighting
matrix during regression fitting [36]. The weighting matrix is a matrix of diagonal







Large off-diagonal numbers of the Covariance matrix are an indication of parameter
correlations, however this is only an indication of the linear dependancies between two
parameters and not between three or more parameters [59].
Covjj is not always representative of the uncertainty in the parameter θj. Covjj is the
true standard error estimate for θj if the other parameter values have been fixed to their
respective optimal values. Covij is the covariance of θi and θj [2].
If parameters are not correlated they are orthogonal. It is often difficult to determine
accurate estimations for parameters, whether they are orthogonal or correlated. Large
covariance values (off diagonal elements) (Cij) may be an indication of parameter
correlation. The larger the covariance values the poorer the parameter identifiability.
This is however not a perfect representation of parameter identifiability as the covariance
values only represent the correlation between two parameters and not between one
parameter and the rest [59, 73].
3.6.1.5 Correlation coefficients
Correlation coefficients are an indication of the degree to which two parameters are
correlated. The correlation coefficients vary between −1.0 and 1.0 where −1.0 is an
indication of a 100% negative correlation between the two parameters while 1.0 indicates
positive correlation. A correlation coefficient of 0 indicates that there is no correlation
between the parameters [75]. The correlation coefficient between two parameters can
be calculated by dividing the covariance between the parameters by the product of the




3.6.1.6 Calculating Asymptotic Confidence Intervals
The method described below works only if the residual values adhere to Gaussian
distribution. This means that if the squared difference values between the measured
data and the model fit are not normally distributed, this method will not return accurate
confidence intervals [92]. This method of calculating the confidence intervals does not
consider the covariance between pairs of parameters [3]. The asymptotic confidence




θ = θ̂ ± δ
√
Covjj
where the constant, δ, ensures that the confidence intervals are correctly calculated for
a specific probability. There are different methods with which to calculate this constant,
one of which is the simple Bonferroni method [62, 73], where δ is calculated as follows:
δ = t α
2r
,n−p
where r is the number of independent variables, α is the significance level, n is the
number of observations and p is the number of parameters.
The parameters will have joint confidence intervals with a coefficient of at least 1− α if
confidence intervals of 100(1− α
2
) percent are constructed for each of the parameters.




With the maximum modulus t procedure δ is calculated as:
δ = uα,r,n−p
where uα,r,n−p is the upper α part of the distribution of the maximum absolute value of
r variables. These variables are independent student-t random variables [73].
The maximum modulus t confidence intervals are generally smaller than the Bonferroni
confidence intervals and the Scheffé confidence intervals are generally larger than
both the Bonferroni and maximum modulus t confidence intervals. The width of the
Scheffé confidence intervals are not influenced by the number of independent variables,




independent variables are involved. When r is very large the Scheffé confidence inter-
vals will be smaller than the Bonferroni and maximum modulus t confidence intervals [73].
The confidence intervals of parameter estimations can also be calculated by multiplying
the standard deviations in the parameters by the Student’s t statistic i.e. setting δ equal
to the Student’s t statistic [3]. The Student’s t statistic (tα
2
,n−p) is read from a table or
calculated by the programming software used. The significance level (α) will be 0.05 for
a 95% confidence level. Half of α and the degrees of freedom are the two values used to
read the t statistic from the table. The degrees of freedom are calculated by subtracting
the number of parameters (p) from the number of observations (n). The scalar value of
the error variance is used and is calculated by dividing the sum of the squared residual
values by the degrees of freedom [62, 73, 92].
This is only one method with which confidence intervals can be calculated. Another
method is the likelihood-based method or finite sample method.
3.6.2 Likelihood-based confidence intervals
Likelihood based confidence intervals are also called finite sample confidence intervals
[89]. As measurement error is a constant factor to consider, likelihood-based confidence
intervals are more accurate descriptions of the confidence intervals. This method is more
reliable under these circumstances as well as when data with minimal information is
used [121]. Advances in computational technology has made it easier to apply likelihood
functions and likelihood ratios to a wide range of problems. There are advantages to
using likelihood-based methods over using asymptotic methods for calculating confidence
intervals [67]. Asymptotic methods depend on symmetric parameter distribution and
accurate, useful standard error estimations [109]. Often asymmetric confidence intervals
(such as likelihood-based confidence intervals) give a more accurate description of the
optimal parameter value estimation and its corresponding confidence interval. It also
works well for smaller data sample sizes as the profile likelihood does not require a
normal distribution of the parameter estimation [20]. The likelihood-based approach is
more reliable in indicating structural non-identifiability than the asymptotic approach
[34].
To calculate the confidence regions for multiple parameters the Chi-squared test
can be used [92]. A likelihood profile for each parameter is created by fixing each
parameter to a value and refitting for all the other parameters. As the possible value
for each parameter is varied, the other parameters are fitted for and the likelihood




interval is thus a range of values of which the likelihood that they could have been
generated by the model is close to the likelihood value of the optimal parameter value [20].
3.6.2.1 Log-likelihood and Profile likelihood
The log-likelihood function is minimised in terms of all parameters except for one which
is kept fixed at a specific value [20, 59]. For each of the values explored within the
possible solution space a maximum log-likelihood value is calculated. This function is
called the profile log-likelihood of the parameter values explored. The antilog thereof is
the profile likelihood. The profile likelihood method works well when it is challenging to
calculate the confidence intervals with other standard methods, for instance when the
function is not normally distributed. This method is also not influenced by the size of
the data set. Other methods, such as the asymptotic Wald method depends on larger
data sets that have normal distributed maximum likelihood estimates [20].
Profile likelihood is used for the identifiability analysis of partially observable models
[64]. The model is refitted to the data and a likelihood-based confidence region is created
for each parameter as the parameter space for each parameter is explored [20, 64].
The parameter space is explored by changing the parameter values slightly and then
refitting for the other parameters [20, 88]. It is also possible to distinguish between
structural and practical non-identifiability with the use of the profile likelihood-based
approach [61, 64, 89]. This profile likelihood that is generated for each parameter
can be subjected to the likelihood ratio test to determine whether the null hypothesis
or alternative hypothesis is accepted. The use of the likelihood ratio test is discussed next.
3.6.2.2 Likelihood ratio test




where L0 is the likelihood under the null hypothesis and L1 is the likelihood under the
alternative hypothesis. The null hypothesis is accepted when Λ > 1 and the alternative
hypothesis is accepted when Λ < 1 [50]. The likelihood ratio test works on the principal
of estimating a parameter with and without a certain constraint and then comparing the








where the number of observations (data points) are represented by n [51]. In cases
when the null hypothesis is rejected (i.e Λ < 1), the null hypothesis is a special case of
the alternative hypothesis. Then the likelihood ratio test statistic follows asymptotic
Chi-squared distribution with q degrees of freedom where q is the difference in the
number of free parameters between the the null and alternative hypotheses. As the
number of observations approach infinity, the likelihood ratio and the log-likelihood
ratio follow a chi-square distribution with 1 degree of freedom. The significance level is
inferred by comparing the likelihood test statistic value to Chi-squared distribution with
1 degree of freedom. The Chi-squared distribution is used to test the significance of the
likelihood ratio test statistic [50, 51, 67, 109].
3.6.2.3 Calculating the likelihood-based confidence intervals
Calculating confidence intervals for a parameter based on the log likelihood ratios are
done by calculating all the values of the parameter for which the log likelihood logL1 is
within a given variation from the optimal parameter value likelihood logL0. θ̂ maximises
the profile likelihood L0. Confidence interval 100(1 − α)% for the parameter θ consists
of all the possible values of the parameter for which the null hypothesis is not rejected [89].





where χ21−α,df is the 1 − α quantile of the Chi-squared distribution with df degrees of
freedom [61, 67, 120]. The upper and/or lower confidence interval limit values are the









The profile likelihood of each parameter and their respective likelihood-based confidence
intervals can be presented as profile likelihood plots. The graphical representation of
these results are often easier to interpret.
3.6.3 Profile likelihood plots
The likelihood-based confidence intervals are often better presented in the form of profile
likelihood plots. These plots are created by fixing one of the parameter values and
refitting for the other parameters. The parameter is fixed to different values across the
solution space. A sum squared residual value is returned for each fit. A smaller SSR
indicates a better parameter estimation, while a larger SSR value is indicative of a worse
fit. If the SSR values increase with a change in the fixed parameter values, the other
parameters are not able to compensate for the change in the fixed parameter value.
Plotting each value in the parameter solution space against its log likelihood estimate
gives a graphical representation of the confidence intervals. The threshold in the
profile likelihood (χ21−α,df ) can also be indicated, making it easy to distinguish whether
parameters have confidence intervals that have upper or lower limits.
Practical non-identifiability is indicated by only either a upper or lower constrained
confidence interval and structural non-identifiability is indicated by confidence intervals
that are neither upper or lower constrained. It is therefor easy to identify practical
or structural non-identifiability by considering the shape of the profile likelihood plots
[61, 89, 109].
Likelihood-based confidence intervals can be calculated with the use of sparse data and
do not require symmetric parameter distribution. This method of calculating confidence
intervals can in some cases be computationally expensive. In contrast, calculating
asymptotic confidence intervals can require less computational power, however, this
method requires normal distribution of parameter estimations and large sample sizes of
data.
Throughout this study the likelihood-based method of calculating confidence intervals
have been used. Profile likelihood plots have been created for all parameters to indicate
identifiability and the likelihood ratio test have been used to calculate confidence intervals.
3.6.3.1 Theoretical example
The example shown in this section illustrates how profile likelihood plots can be used




non-identifiability (as addressed in section 3.5.1). Consider the case where one wishes to
parameterise the dynamics of a certain enzyme of which the kinetics can be described




If another equation, which differs vastly from the Michaelis-Menten equation, shown
above, is used to determine the parameter values, the parameter values will most
likely be structurally non-identifiable; irrespective of the quantity and quality of
the experimental data used for model fitting. Creating a profile likelihood plot of ei-












Figure 3.1: Theoretical example: Profile likelihood plot of a structurally non-
identifiable parameter value. The black line indicates the profile likelihood, the red line
indicates the 95% confidence threshold, and the dashed blue line indicates the parameter
value estimation.
Using the correct equation for model parameterisation, but the experimental data used
is lacking in either quantity or quality could result in parameter values being practically
non-identifiable. The example dataset shown in Figure 3.2A is an example of data lacking
in quantity. The initial rates of these two time courses are below the Km value, as can
be seen in Figure 3.2B. The dynamics of the system can very well be approximated with









































Figure 3.2: Theoretical example: (A) data lacking in quantity resulting in practical
non-identifiability. (B) The initial rates of the time course data is below the Km value












Figure 3.3: Theoretical example: Profile likelihood plot of a practically non-identifiable
parameter value. The black line indicates the profile likelihood, the red line indicates the
95% confidence threshold, the dashed blue line indicates the parameter value estimation,
and the solid blue line indicates the one boundary of the 95% confidence interval.
Identifiable parameter value estimations can be determined with the use of the correct
model, describing the system dynamics, as well as the use of sufficient data. If, for
example, time course datasets that saturate the enzyme is added to the two datasets
shown above, the identifiability of the parameters could be improved. Adding datasets of
which the initial rates are above the Km value (see Figures 3.4A and 3.4B) could result in




3.7. Metabolic control analysis











































Figure 3.4: Theoretical example: (A) data resulting in identifiable parameter value













Figure 3.5: Theoretical example: Profile likelihood plot of an identifiable parameter
value. The black line indicates the profile likelihood, the red line indicates the 95%
confidence threshold, the dashed blue line indicates the parameter value estimation, and
the solid blue lines indicate the boundaries of the 95% confidence interval.
The following section contains an overview of metabolic control analysis techniques used
in the subsequent research chapters.
3.7 Metabolic control analysis
Metabolic Control Analysis (MCA) aids in the understanding of the effects of local
changes on systemic properties. In essence MCA can be seen as sensitivity analysis of
a system. MCA allows one to determine which parts of a biochemical system has the
most control over certain properties of the system. The main use of MCA analysis is to
quantify the change in the steady state variables and fluxes with variation in parameters
or reaction rates [44, 100].
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3.7. Metabolic control analysis
The elasticity, response, and control coefficients need to be determined. MCA is usually
for the analysis of a system under steady state conditions, thus all the coefficients need
to be defined for a specific steady state.
3.7.1 Control Coefficients
The flux control coefficient is an indication of how strongly the rate of reaction k controls




where pk is a parameter that only affects the rate of reaction k (vk). This is the
non-normalised form of the flux control coefficient. ∂vk/∂pk is evaluated with the
parameter values and concentrations associated with the specific steady state.
The change in the flux and the rate is usually normalised by dividing it by the respective






The concentration control coefficient is an indication of how strongly the rate of reaction





Elasticity coefficients give a quantitative measurement of the effect of metabolites or
parameters on the rate of an enzyme [100]. These effects can be due to a change in the
concentration of the enzyme or the metabolites, or a change in a parameter value. These
coefficients are scaled partial derivatives of the kinetic rate equations with respect to
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3.7. Metabolic control analysis





Response coefficients quantify the change in the flux (J) relative to a perturbation in a








3.7.4 Combined Response Theorem
Concentration response coefficients describe the steady state response in a metabolite




3.7.5 Summation and Connectivity Theorems
These theorems give insight into the link between the global properties of a pathway
and the local properties of individual enzymes. Therefore it is possible to determine
the control distribution over the enzymatic pathway which, in turn, relates the system
behaviour to specific branches of the pathway [100].
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3.8. Computational application: Mathematica package
The summation theorem shows quantitively how the control over the flux is distributed







2 + · · ·+ CJn = 1
The summation theorem also applies to the steady state concentrations of the metabo-










2 + · · ·+ Csjn = 0
The flux connectivity theorem shows the relationship between the control coefficients




CJk Evksj = C
J
1 Ev1sj + C
J
2 Ev2sj + · · ·+ C
J
nEvnsj = 0
The control coefficients can also be calculated from the elasticity coefficients [44]:
C = E−1
These MCA techniques have been used throughout all three research chapters in this
study. The following section describes the computational application of the methods
discussed in this chapter and the development of the IdentifiabilityAnalysis
Mathematica package.
3.8 Computational application: Mathematica package
This section is a description of the development of the Mathematica add-on package,
IdentifiabilityAnalysis. This package has been developed to simplify the process of
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3.8. Computational application: Mathematica package
linear or nonlinear regression fitting of an ordinary differential equation (ODE) based
model to experimental data. The model fitting technique used in this study, which has
therefore been included in this packages, is nonlinear least squares regression with the
Nelder-Mead regression method. The use of the functions of this package is not limited
to nonlinear least squares regression problems; although all of the models developed
in this study were nonlinear, the functions in the package are compatible with linear
problems.
The package also includes testing the identifiability of the newly determined parameter
values with the likelihood ratio test and creating profile likelihood plots which give
a visual depiction of the parameter identifiability and confidence intervals. Although
these methods of model parameterisation and identifiability analysis are established and
widely used in various disciplines, Mathematica functions that complete these analyses,
especially the likelihood ratio test and creating the profile likelihood plots, have, to the
best of our knowledge, not been made available for public use. This package allows
the user to parameterise a model, complete identifiability analysis and create profile
likelihood plots with minimal effort and little additional coding needed. The package
is available on request and will be made available on GitHub once the necessary ac-
companying help documentation has been developed. The package includes five functions:
objectiveFunction[modelAndData_, parListNames_, parListVals_]
This function finds the sum squared residual value between the model and the data,
modelAndData, weighted to the variance with the parameters, parListNames, set to the
values, parListVals. The format of modelAndData should be a nested list containing a
list of ODEs, a list of initial values of the variables, a list of the variables, and the data
including the data variance. This nested list can include one entry if only one dataset is
used or multiple entries for the case where the model should be fitted to a number of
experimental datasets. A single value is returned by this Mathematica function. The
objective function in this method is the Chi-squared error criterion discussed in section
3.4.1.1.
minimizeObjectiveFunction[modelAndData_, parList_, minima_, maxima_]
This function finds the solution of the parameters, parList, that returns the smallest
sum squared residual value between the model and the data, modelAndData, weighted
to the variance. The parameters, parList, are constrained by the lower limits, minima,
and the upper limits, maxima. This function uses the built-in Mathematica functions
NDSolve and NMinimize to minimise the objective function. The Nelder-Mead regression
method in section 3.4.3.2 is used by default.
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3.8. Computational application: Mathematica package
profileLikelihood[modelAndData_, parList_, minima_, maxima_, lowlim_,
uplim_, counter_]
This method returns the profile likelihood values for the parameters, parList, of the
model with the accompanying data, modelAndData. One parameter value is varied from
the value lowlim times smaller than the parameter value to the value uplim times larger
than the parameter value for counter number of intervals, while a solution for the other
parameters that returns the smallest sum squared residual value between the model and
the data, weighted to the variance. The parameters, parList, are constrained by the
lower limits, minima, and the upper limits, maxima. This method tests for the identifia-
bility of the parameter values determined by the function minimizeObjectiveFunction.
For each parameter a list of values is returned representing the profile likelihood of that
parameter, as discussed in section 3.6.2.1.
likelihoodRatioTest[dataAll_, pls_, thresholdVal_Real]
This function returns the values of the likelihood ratio test of the profile likelihood values,
pls, for the data, dataAll, used during fitting, for the Chi-square distribution value,
thresholdVal. The user inputs the Chi-square distribution value that corresponds to
one degree of freedom and the desired confidence level. The log likelihood test statistic,
mentioned in section 3.6.2.1, is then calculated according to the number of data points,
taken from dataAll, and the profile likelihood values, pls.
likelihoodRatioPlot[dataAll_, pls_, thresholdVal_Real]
This function returns the plot of the likelihood ratio test of the profile likelihood values,
pls, for the data, dataAll, used during fitting, for the Chi-square distribution value,
thresholdVal. The theory of these profile likelihood plots are discussed in section 3.6.3.





A comparative analysis of
17-OHPROG and A4 synthesis in ovine
and Angora goat models
South Africa is the largest exporter of mohair, currently supplying about 55% of the total
worldwide mohair stock [74]. The industry suffers the loss of young, newly shorn Angora
goats in cold weather. This phenomenon has been studied extensively and it was found
that the Angora goats suffer from altered adrenal function, resulting in hypocortisolism.
Sufficient cortisol synthesis would result in higher blood glucose levels which in turn
allows the animals to survive the cold spells. It was originally hypothesised that reduced
adrenal function in the Angora goats leads to the hypocortisolism seen in these animals
[118]. Later it was found that the reduced cortisol synthesis may be due to increased
CYP17 function relative to 3βHSD function rather than overall reduced adrenal function
[28]. The CYP17 enzyme catalyses three reactions in the Δ4 pathway and two reactions
in the Δ5 pathway. Considering the interlinked dynamics of the Δ4 and Δ5 pathways,
it is difficult to predict the effect of this altered enzymatic function on overall steroid
synthesis without a computational model of Angora steroidogenesis which has to date
not been developed. Such a model would aid in gaining a better understanding as to
how exactly this increased CYP17 activity leads to the hypocortisolism seen in Angora
goats.
The first aim of this chapter is to establish a reference model for healthy cortisol
synthesis. Steroidogenesis in the Merino sheep is used for the development of the
reference model. The second aim of this chapter is to develop a model that describes
the altered adrenal function of the Angora goat. The ovine model is used as a basis for
the development of the Angora model. A comparative metabolic control analysis of the
two models shows the differences in the steroidogenic function of the two species. We
conclude that the increased CYP17 activity in the Angora species causes the Δ5 pathway
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to be favoured with high flux through this pathway even under conditions simulating a
cold stress response.
4.1 Parameterisation and identifiability analysis of
the ovine Δ4 and Δ5 pathways
Both the CYP17 and 3βHSD enzymes contribute to the regulation of steroidogenesis
[27, 28, 38, 39]. Here we expand on the work by E. van Schalkwyk and R. Conradie at
Stellenbosch University, to establish the ovine model as a control model (unpublished
results). In their independent studies, experimental data of metabolite time traces
were collected whereafter data fits and some model validation was done. The model
validation entailed simulating the outcome of time course data not used during the model
construction process. The model is parameterised and validated with experimental data
collected in a reconstituted system with the enzymes CYP17 and 3βHSD expressed
in transfected COS-1 cells. In this section, the work of Van Schalkwyk and Conradie
is combined by pooling the ovine experimental data and reparameterising the model.
Thereafter the model is validated in the same manner as mentioned above. Identifiability
analyses of all parameters of the Δ4 and Δ5 pathways are done, as well as sensitivity
analysis. Neither identifiability analysis nor sensitivity analysis have been conducted on
this system previously.
First, the experimental data collected by Van Schalkwyk and Conradie were combined
and the partial steroidogenic model was reparameterised. All experimental data used
were time course data. These datasets span the Δ4 and Δ5 branches of the steroidogenic
pathway which include the conversion of PREG to PROG, 17-OHPREG, 17-OHPROG,
16-OHPROG, DHEA, and A4 by the enzymes 3βHSD and CYP17, shown in Figure
4.1. The model does not take into account in which zones of the adrenal cortex the
steroids are synthesised. The model works with the average values of the steroids in the
different zones and assumes that the steroid hormones diffuse out of the cells once they
are synthesised.
After our initial reparameterisation of the model, an identifiability analysis of all the
parameters for both enzymes was completed. Although the model has previously been
parameterised, the identifiability of the parameters were not tested. The identifiability
analysis of the preliminary model parameterisations showed non-identifiability of some
parameters; the experimental data used were insufficient to obtain full parameter
identifiability. The non-identifiable parameters were those describing the kinetics of
CYP17. To improve the identifiability, the pool of data needed to be extended and
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additional datasets were included in the study (unpublished data collected by R. Louw).
These datasets included time courses initiated with higher starting concentrations of
the metabolites PREG and PROG to saturate the enzyme, as well as time course
data initiated with the intermediate 17-OHPREG, with which only the conversion of
17-OHPREG to DHEA was measured. The model was parameterised again, with the
additional data, and the identifiability of the parameters were tested. A summary of
the experimental datasets is shown in Tables 4.1 to 4.4. The datasets were grouped into












Figure 4.1: Schematic representation of the Δ4 and Δ5 branches of the steroid
hormone biosynthesis pathway.
The majority of the datasets were used for parameterisation, while only a few were used
for validation to ensure that the most information is assigned towards finding accurate
parameter estimations. The grouping of parameterisation and validation datasets that
returned the maximum number of identifiable parameter values were used. The process
of cross-validation, as defined in [33], was used to divide the data into either the model
construction data or model validation data groups. The validation datasets were not used
for model parameterisation, but rather used to test the model. After parameterisation,
the model was given the initial conditions under which the validation datasets were
collected and asked to predict the outcome of the time course experiments.
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Table 4.1: 3βHSD Model parameterisation data: Initial concentrations of sub-
strates, intermediates and products of the 3βHSD experimental assays completed by Van
Schalkwyk. All assays were completed in triplicate [119].
Assay
Time
Initial substrate(s) Metabolites measured Figure
7h 5 μM PREG, 5 μM PROG PREG, PROG Fig. 4.2 A
7h 2 μM PREG PREG, PROG Fig. 4.2 B
7h 5 μM PREG PREG, PROG Fig. 4.2 C
7h 3 μM PREG, 3 μM PROG PREG, PROG Fig. 4.3 G
7h 3 μM PREG PREG, PROG Fig. 4.4 B
7h 1.88 μM 17-OHPREG,
2.12 μM 17-OHPROG
17-OHPREG, 17-OHPROG Fig. 4.2 D
7h 2 μM 17-OHPREG 17-OHPREG, 17-OHPROG Fig. 4.3 A
7h 3.38 μM 17-OHPREG,
6.62 μM 17-OHPROG
17-OHPREG, 17-OHPROG Fig. 4.3 B
7h 5 μM 17-OHPREG 17-OHPREG, 17-OHPROG Fig. 4.3 C
7h 3 μM 17-OHPREG,
3 μM 17-OHPROG
17-OHPREG, 17-OHPROG Fig. 4.3 H
7h 3 μM 17-OHPREG 17-OHPREG, 17-OHPROG Fig. 4.4 C
7h 2 μM DHEA DHEA, A4 Fig. 4.3 D
7h 5 μM DHEA DHEA, A4 Fig. 4.3 E
7h 5 μM DHEA, 5 μM A4 DHEA, A4 Fig. 4.3 F
7h 3 μM DHEA, 3 μM A4 DHEA, A4 Fig. 4.4 A
7h 3 μM DHEA DHEA, A4 Fig. 4.4 D
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Table 4.2: CYP17 Model parameterisation data: Initial concentrations of sub-
strates, intermediates and products of the CYP17 experimental assays completed by Van
Schalkwyk and R. Louw. The first four assays were completed by R. Louw (unpublished
results) and the last three assays were completed by Van Schalkwyk [119]. All assays
were completed in triplicate.
Assay
Time
Initial substrate(s) Metabolites measured Figure
12h 2.5 μM PREG, 1 μM PROG PREG, PROG, 17-OHPREG,
17-OHPROG, DHEA, A4
Fig. 4.5 A &
Fig. 4.5 B
6h 5 μM PREG PREG, 17-OHPREG, DHEA Fig. 4.5 C
12h 5 μM 17-OHPREG 17-OHPREG, DHEA Fig. 4.5 D
12h 1.5 μM PROG PROG, 17-OHPROG,
16-OHPROG, A4
Fig. 4.5 E
12h 2 μM PROG PROG, 17-OHPROG,
16-OHPROG, A4
Fig. 4.5 F
12h 3 μM PROG PROG, 17-OHPROG,
16-OHPROG, A4
Fig. 4.5 G
6h 5 μM PROG PROG, 17-OHPROG, A4 Fig. 4.5 H
Table 4.3: 3βHSD Model validation data: Initial concentrations of substrates, inter-
mediates and products of the 3βHSD experimental assays completed by Van Schalkwyk.
All assays were completed in triplicate [119].
Assay
Time
Initial substrate(s) Metabolites measured Figure
7h 2 μM PREG, 2 μM PROG PREG, PROG Fig. 4.6 A
7h 5 μM 17-OHPREG,
5 μM 17-OHPROG
17-OHPREG, 17-OHPROG Fig. 4.6 C
7h 1.15 μM 17-OHPREG,
2.85 μM 17-OHPROG
17-OHPREG, 17-OHPROG Fig. 4.6 D
7h 2.23 μM DHEA, 1.77 μM A4 DHEA, A4 Fig. 4.6 B
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Table 4.4: CYP17 Model validation data: Initial concentrations of substrates, inter-
mediates and products of the CYP17 experimental assays completed by Van Schalkwyk,
Conradie, and R. Louw. The first assay was completed by Conradie (unpublished re-
sults), the second assay was completed by R. Louw (unpublished results), and the third
assay was completed by Van Schalkwyk [119]. All assays were completed in triplicate.
Assay
Time
Initial substrate(s) Metabolites measured Figure
13h 2 μM PREG PREG, 17-OHPREG, DHEA Fig. 4.7 A
12h 4 μM PREG, 1 μM PROG PREG, PROG, 17-OHPREG,
17-OHPROG, DHEA, A4
Fig. 4.7 B &
Fig. 4.7 C
12h 3 μM PREG, 3 μM PROG PREG, PROG, 17-OHPREG,
17-OHPROG, DHEA, A4
Fig. 4.7 D &
Fig. 4.7 E
4.1.1 Model parameterisation and validation
The ovine model is described as rate equations 4.1 and 4.2 and a set of ordinary
differential equations 4.3. Michaelis-Menten kinetics are used to describe CYP17 and
3βHSD. All reactions catalysed by these enzymes are irreversible. CYP17 is not affected
by product inhibition, but 3βHSD is, this is reflected in the denominators of the rate
equations. The regression method used is weighted least squares fitting of the model to
the experimental data as stated on page 20. The function minimizeObjectiveFunction
of the Mathematica add-on package IdentifiabilityAnalysis was used. All exper-
iments were completed in triplicate, therefore the standard deviation of each of the
experimental data points were used for weighting the individual sum of the squared
residual values. The experimental design and experimental conditions under which the
data were collected is explained in [119]. Figures 4.2 to 4.4, and Figure 4.5 and shows
the data used for the parameterisation of the enzymes 3βHSD and CYP17 respectively.
These plots show the experimental data points as well as the fit of the model to the data
that corresponds to the fitted solution for the parameter values. Poor fits of the model
to some of the experimental data can be seen in these figures. However, with the limited
amount of data available for model construction, the choice was made not to exclude
any data as outlier datasets. Figures 4.6 and 4.7 show the validation data used to test
the newly parameterised model. The model was asked to predict the outcome of these
experimental conditions, given the initial metabolite concentrations. The validation of
the 3βHSD parameter values show accurate model predictions of the data, however, in
Figure 4.7 B an over estimation of the initial reaction is shown. The model predicts an
initial influx of substrate as too high. However, considering Figures 4.7 A, C, D, and E,
which show accurate model predictions, the model is able to predict the majority of the
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validation data accurately.




















































































4.1. Parameterisation and identifiability analysis of the ovine Δ4 and Δ5 pathways
4.1.1.3 Ordinary Differential Equations
d
dt
[PREG] = −v1 − v6
d
dt
[17OHPREG] = v1 − v2 − v7
d
dt
[DHEA] = v2 − v8
d
dt
[PROG] = v6 − v3 − v4
d
dt






[A4] = v5 + v8
(4.3)
A B


















PREG → PROG via 3βHSD
PREG
PROG







































PREG → PROG via 3βHSD
PREG
PROG

















17OHPREG → 17OHPROG via 3βHSD
17OHPREG
17OHPROG
Figure 4.2: Model fit to 3βHSD data. Model fit (solid lines) to the experimental
data (points) used for the parameterisation of 3βHSD parameters. The 95% confidence
intervals are indicated by the grey areas.
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17OHPREG → 17OHPROG via 3βHSD
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17OHPREG → 17OHPROG via 3βHSD
17OHPREG
17OHPROG







































DHEA → A4 via 3βHSD
DHEA
A4











































PREG → PROG via 3βHSD
PREG
PROG



















17OHPREG → 17OHPROG via 3βHSD
17OHPREG
17OHPROG
Figure 4.3: Model fit to 3βHSD data (continued). Model fit (solid lines) to the
experimental data (points) used for the parameterisation of 3βHSD parameters. The
95% confidence intervals are indicated by the grey areas.
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DHEA → A4 via 3βHSD
DHEA
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17OHPREG → 17OHPROG via 3βHSD
17OHPREG
17OHPROG



















DHEA → A4 via 3βHSD
DHEA
A4
Figure 4.4: Model fit to 3βHSD data (continued). Model fit (solid lines) to the
experimental data (points) used for the parameterisation of 3βHSD parameters. The
95% confidence intervals are indicated by the grey areas.
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PROG → 17OHPROG → A4 via CYP17






















PROG → 17OHPROG → A4 via CYP17

























PROG → 17OHPROG → A4 via CYP17



























Figure 4.5: Model fit to CYP17 data. Model fit (solid lines) to the experimental
data (points) used for the parameterisation of CYP17 parameters. The 95% confidence
intervals are indicated by the grey areas.
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PREG → PROG via 3βHSD
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17OHPREG → 17OHPROG via 3βHSD
17OHPREG
17OHPROG

















17OHPREG → 17OHPROG via 3βHSD
17OHPREG
17OHPROG
Figure 4.6: Model validation of the 3βHSD parameters. The experimental data
(points) are shown along with the model prediction (solid lines).
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Figure 4.7: Model validation of the CYP17 parameters. The experimental data
(points) are shown along with the model prediction (solid lines).
This grouping of the datasets into the respective construction and validation combinations
returned the maximum number of identifiable parameter estimations, as discussed below.
4.1.2 Identifiability analysis
The method chosen to evaluate the identifiability of parameter estimations is the
likelihood ratio test and profile likelihood plots as described on page 32. The functions
profileLikelihood and likelihoodRatioPlot of the Mathematica add-on package
IdentifiabilityAnalysis were used. An identifiability analysis was done on each
of the parameter estimations of both the CYP17 and 3βHSD enzymes and confidence
intervals for the newly determined parameter values were calculated.
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Figure 4.8: Identifiability analysis of 3βHSD V max6, KmPreg3BHSD and
KmProg3BHSD for the conversion of PREG to PROG. Both V max6 and
KmPreg3BHSD are identifiable as these parameters are constrained within upper and
lower bound confidence intervals. KmProg3BHSD is not identifiable as this parameter
is not constrained by an upper limit. The red lines indicate the 95% confidence cut-off
value.
Figure 4.8 shows the profile likelihood plots for the three parameters V max6, KmPreg
and KmProg for the conversion of PREG to PROG by 3βHSD, the only 3βHSD reaction
with a non-identifiable parameter value. Both V max6 and KmPreg are identifiable as
they are constrained within confidence intervals with upper and lower limits. KmProg
is practically non-identifiable as it is only constrained by a lower limit confidence
interval. This practical non-identifiability is a consequence of it being difficult to obtain
experimentally high enough concentrations of product formation to fully parameterise
and identify the product inhibition of 3βHSD by PROG. The practical non-identifiability
can be considered in a quantitative sense, for instance if the 95% confidence is lowered
to a 90% confidence, the parameter KmProg of 3βHSD would be identifiable. However,
the 95% confidence level was used throughout, even though decreasing the confidence
would in some cases have increased the number of identifiable parameters. All other
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3βHSD parameter values were determined identifiably. The parameter values and their
corresponding confidence intervals can be seen in Table 4.5. The profile likelihood plots
of the other 3βHSD parameters can be seen in Appendix A on page 134.
Figure 4.9 shows the two profile likelihood plots for the parameters V max5 and
Km17OHProg for the conversion of 17-OHPROG to A4 by CYP17, the only CYP17
reaction with non-identifiable parameter values. These parameters are practically non-
identifiable. The synthesis of A4 from 17-OHPROG via CYP17 is very low in the ovine
species. The practical non-identifiability seen is due to the very low flux through this
branch of the steroidogenic pathway [81]. All the other parameter values for the CYP17
enzyme were determined identifiably. These values and the confidence intervals can be






































































Figure 4.9: Identifiability analysis of CYP17 V max5 and Km17OHProgCY P17 for the
conversion of 17OH-PROG to A4. Neither of these two parameters are identifiable
as they are only constrained by lower limit confidence values. The red lines indicate the
95% confidence cut-off value.
Table 4.5: 3βHSD Parameter values and confidence intervals (CI)
Parameter Identifiability Optimal value Lower bound Upper bound
95% CI 95% CI
V max6 Identifiable 2.05319 (μM/h) 1.8725 2.30213
V max7 Identifiable 2.82952 (μM/h) 2.01085 4.87385
V max8 Identifiable 1.16183 (μM/h) 1.08423 1.24653
KmPreg3BHSD Identifiable 1.21769 (μM) 0.936352 1.64809
KmProg3BHSD Not identifiable 31.39936 (μM) 16.5813 Indeterminate
Km17OHPreg3BHSD Identifiable 2.19637 (μM) 1.04871 5.60575
Km17OHProg3BHSD Identifiable 1.63111 (μM) 0.766163 3.90764
KmDHEA3BHSD Identifiable 0.23452 (μM) 0.15664 0.344214
KmA43BHSD Identifiable 0.217207 (μM) 0.135017 0.353842
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Table 4.6: CYP17 Parameter values and confidence intervals (CI)
Parameter Identifiability Optimal value Lower bound Upper bound
95% CI 95% CI
V max1 Identifiable 1.67292 (μM/h) 1.36737 2.11747
V max2 Identifiable 0.152892 (μM/h) 0.12613 0.175953
V max3 Identifiable 0.798223 (μM/h) 0.722805 0.899345
V max4 Identifiable 0.0171024 (μM/h) 0.0123062 0.0215451
V max5 Not identifiable 0.0777709 (μM/h) 0.0192489 Indeterminate
KmPregCY P17 Identifiable 0.550419 (μM) 0.298424 0.883136
KmProgCY P17 Identifiable 0.884594 (μM) 0.263981 1.09416
Km17OHPregCY P17 Identifiable 0.17159 (μM) 0.0467976 0.213687
Km17OHProgCY P17 Not identifiable 5.98839 (μM) 0.680454 Indeterminate
4.2 Establishing the ovine model as a control model:
Comparison with results in literature
In this section the newly parameterised ovine model is validated against results in
literature. The model is first validated by predicting the experimental results of a study
by Engelbrecht and Swart [28]. Thereafter the model is used to simulate the theoretical
results of a study by Nguyen et al [81]. These validations of the model against literature
results establishes the model as valid reference model for steroid synthesis.
4.2.1 Simulating experimental results for the ovine species
In section 4.1 the model is parameterised with experimental data collected in a reconsti-
tuted system with the enzymes CYP17 and 3βHSD expressed in transfected COS-1 cells.
The Vmax and Km values for the substrates and products of the conversion of one steroid
to the next were determined. In the model these Vmax values are the total enzyme
concentration times the catalytic rate constant of the enzyme for a specific conversion
[95]. With variation in the transfection efficiency in in vitro studies and unknown
expression levels of the enzyme in in vivo studies, it is not always possible to determine
the true Vmax values. In this section the Vmax values are adjusted to account for the
unknown expression of the enzymes in the published study. This is done by adding a
variable multiplier to the rate equation which is then fitted for. This is a necessary step
when comparing model predictions to results of other independent studies when the
enzyme concentration is unknown.
The model is validated by simulating the outcome of experiments not conducted with
transfected cells, but rather the adrenal microsomes from harvested animal tissue.
By adjusting the Vmax values of the model to account for the enzyme expressions in
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the published study, the ratio of the enzyme activities are also adjusted to represent
physiological enzyme expression. This validation tests whether the model can predict
the steroidogenesis in ovine adrenal microsomes. In the study by Engelbrecht and Swart,
the adrenal steroidogenesis of the Angora goat was compared to that of the Merino
sheep and Boer goat. Both the Boer goat and Merino sheep are considered to be hardy
species which do not suffer from the hypocortisolism seen in the Angora goats. If the
model can accurately predict the outcome of the ovine results in the study, it can be
used as a reference model for steroidogenic function.
Figure 4.10: 3βHSD and CYP17 activity in Angora goat, Boer goat and Merino
sheep adrenal microsomes. (a) Comparison of 3βHSD activity in Angora goats, Boer
goat and Merino sheep adrenal microsomes by measuring the conversion of 10μM PREG
to PROG. (b) Comparison of CYP17 activity in Angora goats, Boer goat and Merino
sheep adrenal microsomes by measuring the conversion of 10μM PREG to 17-OHPREG
and DHEA. The figure axis is labeled only as the the production of DHEA, but this
should be labeled as the the production of DHEA and 17-OHPREG in total (confirmed
by author). Figure taken directly from [28].
In the study by Engelbrecht and Swart, the microsomes from the adrenal glands of
freshly slaughtered animals were used to collect steroidogenic data [28]. Figure 4(a)
in the study, shown here in Fig 4.10(a), compares the 3βHSD activity of the Angora
goat, Boer goat and Merino sheep. This was done by comparing the conversion of 10μM
PREG to PROG between the species. Figure 4(b) in the study, shown here in Fig
4.10(b), compares the CYP17 activity of these three species by measuring the conversion
of 10μM PREG to 17-OHPREG and DHEA. The activity of each of the enzymes were
studied independently of the other by adding the appropriate cofactors to the adrenal
microsome reaction mixture. NADPH was added to measure the activity of CYP17 for
59
Stellenbosch University https://scholar.sun.ac.za
4.2. Establishing the ovine model as a control model: Comparison with results in
literature
the conversion of PREG to 17-OHPREG and DHEA and the cofactor NAD+ was added
to measure the activity of 3βHSD for the conversion of PREG to PROG [28].
Engelbrecht and Swart1040
Figure 1. Typical HPLC elution profiles of 10 !M An-
gora goat progesterone metabolites separated on a C18
column (280 × 6 mm) at a) 0, b) 6, and c) 15 min. The mobile
phase consisted of solvent A (water:methanol, 40:60) and
solvent B (methanol). Separation was achieved by elution
with solvent A for 15 min followed by a linear gradient
from 100% A to 100% B for 10 min and a further 10-min
isocratic elution with solvent B at a flow rate of 2 mL/
min. Steroid concentrations were determined from the
peak areas (a linear relation was found between concen-
tration and peak area) (PROG: progesterone, DOC: de-
oxycorticosterone, DOCL: deoxycortisol).
Figure 2. Time course of progesterone (PROG) metabo-
lism by Angora goat (A), Boer goat (B), and Merino sheep
(M) adrenal microsomes. The microsomes (.32 mM P450)
were incubated with 10 !M progesterone at 37°C with
constant stirring. The products were extracted and subse-
quently separated and quantified with a HPLC system
as described elsewhere. The results were statistically ana-
lyzed by comparing the species’ cortisol levels to that at 0
min and are indicated on the respective graphs (repeated
measures ANOVA, followed by Dunnet). The cortisol
levels of each species were also compared with the re-
sponse of the other animals (repeated measures ANOVA,
followed by Bonferroni) (inset: Statistical comparison).
Androstenedione and 17OH-progesterone production
were insignificant (DOC: deoxycorticosterone, DOCL:
deoxycortisol).
Engelbrecht and Swart1040
Figure 1. Typical HPLC elution profiles of 10 !M An-
gora goat progesterone metabolites separated on a C18
column (280 × 6 mm) at a) 0, b) 6, and c) 15 min. The mobile
phase consisted of solvent A (water:methanol, 40:60) and
solvent B (methanol). Separation was achieved by elution
with solvent A for 15 min followed by a linear gradient
from 100% A to 100% B for 10 min and a further 10-min
isocratic elution with solvent B at a flow rate of 2 mL/
min. Steroid concentrations were determined from the
peak areas (a linear relation was found between concen-
tration and peak area) (PROG: progesterone, DOC: de-
oxycorticosterone, DOCL: deoxycortis l).
Figure 2. Time course of progesterone (PROG) metabo-
lism by Angora goat (A), Boer goat (B), and Merino sheep
(M) adrenal microsomes. The microsomes (.32 mM P450)
were incubated with 10 !M progesterone at 37°C with
constant stirring. The products were extracted and subse-
quently separated and quantified with a HPLC system
as described elsewhere. The results were statistically ana-
lyzed by comparing the species’ cortisol levels to that at 0
min and are indicated on the respective graphs (repeated
measures ANOVA, followed by Dunnet). The cortisol
levels of each species were also compared with the re-
sponse of the other animals (repeated measures ANOVA,
followed by Bonferroni) (inset: Statistical comparison).
Androstenedione and 17OH-progesterone production
were insignificant (DOC: deoxycorticosterone, DOCL:
deoxycortisol).
Figure 4.11: Time course ata of 10μM PROG metabolism by Angora goat,
Boer goat and Merino sheep microsomes. Figure adapted from Fig. 2 in [28].
Figure 2 in the stu y, shown here in Fig. 4.11, compares the conversion of PROG to
17-OHPROG, DOC (Deoxycorticosterone), DOCL (Deoxycortisol), and A4 between
the three species. This experiment was also conducted with the microsomes from the
adrenal gl n s of the three differ nt species. The CYP17 enzyme converts PROG
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to 17-OHPROG and in turn converts 17-OHPROG to A4, while the CYP21 enzyme
converts PROG and 17-OHPROG to DOC and DOCL respectively. The syntheses of
17-OHPROG and A4 were insignificant and therefore not published in their study. The
experiment was initiated with 10μM PROG.
All of the above mentioned experiments were normalised with the adrenal P450 content
(0.32 mM P450). The P450 concentration was determined by spectrophotometric assays.
The total protein was not recorded.
To validate the newly parameterised ovine model, simulations of these experimental
results were created. The expression levels of the CYP17, 3βHSD, and CYP21 enzymes
in the adrenal glands of the sheep, used in these experiments, are unknown. To account
for the unknown expression levels in this study, three multipliers were fitted for, α, β,
and γ. These multipliers represent the expression of the enzymes 3βHSD, CYP17, and
CYP21 respectively. Although fitted for, these multipliers do adhere to constraints. The
values of α and β are firstly fitted for by using the two time courses of Merino sheep
data in Figure 4.10. In all subsequent analysis, the values of α and β are fixed, and not
fitted for again. When the multiplier γ is fitted for, with some of the time course data
of Figure 4.11, the values of the other variable multipliers are fixed to their previously
determined values. During the fitting for the variable multipliers and all further model
simulations, the values of the 18 parameters, present in the model, were fixed to the
values in Tables 4.5 and 4.6, as previously determined.
The α and β multipliers were fitted for by using the Merino sheep data points of Fig.
4.10(a) and Fig. 4.10(b) respectively. Engelbrecht and Swart studied the kinetics of
3βHSD and CYP17 independently by adding the appropriate cofactors. Fig. 4.10(a)
show only the kinetics of 3βHSD and Fig. 4.10(b) show only the kinetics of CYP17. The
ovine model was simplified to mimic the experimental conditions of these two figures by
setting the rate equations of the pathway branches, not present in the experiment, equal
to zero. The resulting rate equations for the fitting of α and β are equations 4.4 and 4.6
respectively, while the ODEs are equations 4.5 and 4.7. To fit for α and β an objective
function in Mathematica finds the optimal solution for these multipliers by minimising
the distance between the time course data for the Merino sheep of Fig. 4.10(a) and
4.10(b) and the model simulation. The model simulation of the time course data in Fig.
4.10(a) and 4.10(b) can be seen in Fig. 4.12. The values identified as the optimal and
identifiable solutions for the parameters, shown in Tables 4.5 and 4.6, were used as the
values for the parameters in equations 4.4 to 4.10. The fitted values for α and β are 43.86
and 56.96 respectively. These two values are used in all subsequent analysis to adjust for
the relative expression of 3βHSD and CYP17 in the ovine species.
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Rate equation for determining the activity of 3βHSD:
v1 =


















Rate equations for determining the activity of CYP17:
v2 =
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Figure 4.12: Model simulation of Fig 4.10(a) and 4.10(b) where the multipliers
α and β are fitted for. The model simulation is depicted as the solid line and the time
course data for the Merino sheep from the Fig. 4.10 are shown as the black data points.
Data is converted to concentration data (μM). The 95% confidence intervals of the model
simulation is shown by the grey areas.
The multiplier γ represents the expression of the CYP21 enzyme in the experiment shown
in Fig. 4.11. CYP21 converts PROG and 17-OHPROG to DOC and DOCL respectively.
These two branches of the pathway have not yet been included in our model, therefore
mass action kinetics were used to account for the synthesis of DOC and DOCL. In the
study by Engelbrecht and Swart the initial rate of DOC production was found to be 0.25
nmol·mL-1·min-1 and that of DOCL was found to be 0.13 nmol·mL-1·min-1 [28]. Only
one variable multiplier is fitted for for both branches by including the ratio of DOC
formation relative to DOCL formation. Therefore the formation of DOC is equivalent to
the constant value of γ times the concentration of PROG and the formation of DOCL is
equivalent to γ times the concentration of 17-OHPROG and the ratio of 0.13/0.25, see
equations 4.9 and 4.10.
The value of 56.96 for the multiplier β was substituted into equation 4.8. With the value
for β determined for one experiment, we simulated the results of another experiment in
the study.
The multiplier γ was fitted for by using the Merino sheep data points of Fig. 4.11.
The model was simplified to mimic the experimental conditions of this figure by setting
the rate equations of the pathway branches, not used in the experiment, equal to zero.
Although the conversion of PROG to 16-OHPROG is included in this model for the
ovine species, the levels of 16-OHPROG accumulation is low enough that the inclusion
or exclusion of 16-OHPROG formation has no effect on overall PROG consumption and
17-OHPROG formation. It has therefore been excluded from these model simulations.
The resulting rate equations are 4.8 to 4.10 and the ODEs are 4.11. These equations are
fitted to the experimental data in Fig. 4.11 and the model simulation of the experimental
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time course data can be seen in Fig. 4.13. From a formal mathematical perspective
the model could be rejected because the experimental data points fall outside the 95%
confidence intervals. However, from a biological perspective, the model was constructed
with data from a different system (transfected cells) than the microsome system of which
the dynamics is predicted in Fig. 4.13. The model, being able to predict the outcome
of the microsome data to the level of accuracy seen in Fig. 4.13, is a useful tool for
studying the steroidogenic dynamics in this system.
Rate equations for determining the expression of CYP21:
v4 =










v5 = γ · [PROG] (4.9)




ODEs for PROG conversion to 17-OHPROG, DOC, and DOCL:
d
dt
[PROG] = −v4 − v5
d
dt
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Figure 4.13: Model simulation of Fig. 4.11 where the multiplier γ is fitted for.
The model simulation is depicted as the solid line and the time course data for the Merino
sheep from the Fig. 4.11 is shown as the black data points. The 95% confidence intervals
of the model simulation is shown by the grey areas.
With the values of α, β and γ determined, the results of another experiment, published
in the same study by Engelbrecht and Swart, were predicted [28]. The experimental
results for the percentage metabolite distribution of 10 μM PREG metabolism in the
adrenal microsomes of the Merino sheep (Table 1 in the study [28]) are shown here in
Table 4.7. This table also contains the model prediction of these experimental results;
the percentage conversion of 10μM PREG to DOC, DOCL, 17-OHPREG, DHEA,
and A4 with the simulation allowed to run to completion. The model was given the
initial metabolite concentrations, used to conduct the experiment, and predicted the
intermediate and product synthesis. When comparing the model simulation with the
Merino sheep data, the synthesis of DOC and DOCL, and DHEA and 17-OHPREG are
fairly similar. The ovine model predicted the synthesis of DOC and DOCL to be 80.65%
of the total metabolite formation, while 0% DHEA and 17-OHPREG were formed. The
published result was a value of 82.03% for DOC and DOCL synthesis, while DHEA and
17-OHPREG synthesis were also 0% in the sheep microsomes. The model predicted the
synthesis of A4 being 18.39% of the total metabolite distribution while 0% of the PREG
remained, it is however uncertain what the A4 synthesis and remaining PREG were in
the ovine microsomes as the values were not published.
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Table 4.7: Percentage metabolite distribution of 10 μM PREG metabolism
in the adrenal microsomes of the Merino sheep (taken from [28]) and the model





% A4 % PREG
Merino sheep microsomes 82.03 0.00 - -
Model prediction 80.65 0.00 18.39 0.00
With these same values of α, β and γ for the relative expression of CYP17, 3βHSD, and
CYP21, the model was used to simulate the outcome of another independent experiment
completed by Engelbrecht [26]. The effect of PREG on the production of PROG was
studied. The production of 17-OHPROG, DOC, and DOCL was recorded in the presence
and in the absence of 10 μM PREG. Similarly to the experimental conditions of the
study by Engelbrecht and Swart [28], these experiments were also conducted with the
microsomes from the adrenal glands of the Angora goats, Merino sheep, and Boer goats.
This experiment was normalised with the value of 0.22 mM P450. With the multipliers
α, β, and γ fitted to experimental data normalised with the value of 0.32 mM P450, the
multipliers were scaled with the ratio of 0.22/0.32 for the simulation of these results.
The experimental Merino sheep results of this experiment are summarised in Table 4.8
as well as the model prediction of this experiment for the Merino sheep.
Table 4.8: Products of 10 μM PROG metabolism in Merino sheep adrenal
microsomes in the presence and absence of 10 μM PREG in the incubation
mixture (taken from [28]) and the model prediction thereof.
%PROG remaining %17OHPROG & DOC %DOCL
No 10μM No 10μM No 10μM
PREG PREG PREG PREG PREG PREG
Merino
sheep 4 48 64 41 31 10
Model
prediction
1.97 15.65 79.78 67.10 17.33 6.97
In their study it was found that all three species metabolised less PROG in the presence
of PREG. In the Merino sheep the amount of unmetabolised PROG increased 12 times,
our model showed nearly a 10 times increase in unmetabolised PROG. It was also found
that the Merino sheep produces less DOCL, 17-OHPROG and DOC in the presence of
PREG than in the absence thereof. Their study showed a 36% decrease in 17-OHPROG
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and DOC production, while our results showed a 16% decreased in the production of
these metabolites. The production of DOCL decreased with 68%, with our model show-
ing a decrease of 60% [26]. Our model is fairly successful in predicting the same trends in
steroid synthesis, in the presence and absence of PREG, as seen in the experimental study.
The results of this section indicate that the ovine model can adequately simulate the
results of experimental data generated with ovine adrenal microsomes, shown in Table
4.7. The ovine model could also qualitatively predict the relative difference in steroid
synthesis in the presence and the absence of PREG (Figure 4.8).
4.2.2 Simulating theoretical results for the ovine species
In this section the ovine model is validated against a theoretical model in literature.
The model by Nguyen et al [81] describes steroidogenesis in the human, non-human
primates, ovine, and bovine species. As an additional validation of our ovine model the
results published in the Nguyen study is recreated.
As mentioned in the previous chapter, a paradoxical increase of E2 is seen in rhesus
monkeys and sheep with inhibition of 3βHSD [81]. A4 is a precursor for E2. Figure
4.14 shows the Δ4 and Δ5 branches of the steroid hormone biosynthesis pathway as
modelled by Nguyen et al [81]. This model of the pathway does not include the CYP17
reaction where 17-OHPROG is converted to A4 as this reaction does not take place
in all mammals. As such, 3βHSD is the only enzyme facilitating the synthesis of A4.
It is therefore counterintuitive to see an increase in E2 synthesis when 3βHSD is inhibited.
The Nguyen model showed that with negligible conversion of 17-OHPROG into A4 via
CYP17, A4 production can be increased with decreased 3βHSD activity. In their study
it is shown that a constant decrease in 3βHSD activity causes a constant decrease in the
production of PROG and 17-OHPROG. However, with decreased 3βHSD activity A4
production is increased up to a certain point, but further decrease in 3βHSD activity
leads to a sharp decrease in A4 synthesis. Sensitivity analysis showed that these results
are only dependent on Vmax values. Their study also showed that a decrease in the
affinity of CYP17 for PREG (increasing the Km value 10-fold) showed similar qualitative
results [81]. This phenomenon in A4 production is also seen in in vivo systems. Rhesus
monkeys produce more E2 during the mid-luteal phase of the menstrual cycle. In
another example lutectomised and ovarectomised 90-day pregnant ewes produce more
E2 when 3βHSD is inhibited by trilostane [24, 81, 122].
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Figure 4.14: Schematic representation of the Δ4 and Δ5 branches of the steroid
hormone biosynthesis pathway as modelled by Nguyen et al [81].
















































































Figure 4.15: Decreased synthesis of PROG and 17-OHPROG, and increased
synthesis of A4 seen with decreased 3βHSD activity. The concentration of A4
rapidly decreases with further decrease in 3βHSD activity beyond a certain point.
This paradoxical increase in E2 seen with a decrease in 3βHSD activity can also be
simulated with our model (Fig. 4.15). A4 is a precursor for E2 and with a decrease
in the activity of 3βHSD, an increase in A4 synthesis can be simulated. A decrease in
the activity of 3βHSD beyond a certain point then also leads to a sharp decrease in A4
synthesis. However, a steady decrease in enzyme activity leads to constant decreased
synthesis of 17-OHPROG and PROG. These simulations correspond to the behaviour
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of the model by Nguyen et al [81]. Sensitivity analysis on our model also showed that
similar qualitative results are returned with variation in all other parameter values,
apart from the activity of 3βHSD. The ratio of the activities of CYP17 and 3βHSD also
does not have any influence i.e. a constant increase in the activity of CYP17 does not
return the same results. This phenomenon is only seen with a decrease in the activity of
3βHSD.
The Nguyen model also showed that increased PREG supply initially increases the pro-
duction of all metabolites. Their steady state analysis showed that increasing the PREG
supply rate beyond a certain level decreases the production of A4, then DHEA, and
finally 17-OHPROG, but continually increases PROG production. Sensitivity analysis
showed that these results remain unchanged with variation in all other parameter values,
apart from the PREG supply [79].











































































































Figure 4.16: Changes in steady state concentrations of PROG, A4, DHEA, and
17-OHPROG with varying PREG supply rate. The PREG supply ranges from 0
to 5 μM/h. The steady state concentration of A4 decreases first when the PREG supply
rate nearly reaches 0.4 μM/h. The steady state concentration of DHEA decreases next,
once the PREG supply rate reaches 1.0 μM/h, while the concentration of 17-OHPROG
decreases last, once the PREG supply is just above 1.0 μM/h
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These results could also be simulated with our model. Figure 4.16 shows that an increase
in the supply rate of PREG causes a continuous increase in the PROG steady state
concentration. Figure 4.16 also shows an initial increase in A4, DHEA, and 17-OHPROG
production with an increase in the PREG supply rate, but then a decrease in metabolite
production is seen with further increase in PREG supply. Similar to the results obtained
with the Nguyen model, our model shows a suppression of A4 synthesis first, then the
suppression of DHEA, and finally the production of 17-OHPROG is suppressed with
increase in PREG supply beyond a certain rate.
The results in this section and the previous section show that the newly parameterised
ovine model could fairly accurately simulate the results of two independent studies in
literature. Thus the ovine model can be used further as a reference model for healthy
steroidogenesis in the process of studying hypocortisolism in Angora goats.
4.3 Development of the Angora model
In this section we use the ovine model, as parameterised and validated in the previous
sections, to create a model that represents the steroidogenesis in the Angora goat. The
Angora model is parameterised by combining the ovine model with the altered enzyme
activities of the Angora goat (taken from the study by Engelbrecht and Swart [28]),
whereafter the model is validated against an independent study in literature.
Engelbrecht and Swart found that the activity of the 3βHSD enzyme was 0.53
nmol.mL-1.min-1 for the conversion of PREG to PROG and the activity of CYP17 was
0.5 nmol.mL-1.min-1 for the conversion of PREG to DHEA in the Merino sheep. These
activities were measured using the microsomal subcellular fractions of the homogenised
adrenal microsomes of seven Merino sheep ewes, resuspended in 100 mM potassium
phosphate buffer. The activity of these two enzymes are similar in the ovine species,
but in the Angora goat the activity of CYP17 is higher than that of 3βHSD with
3βHSD having an activity of 0.5 nmol.mL-1.min-1 while CYP17 has an activity of 1.13
nmol.mL-1.min-1 [28]. These activities were measured using the microsomal subcellular
fractions of eight Angora goat ewes, resuspended in 100 mM potassium phosphate
buffer. The activity of CYP17 is more than twice (2.26 times) that of 3βHSD in the
Angora goat. Increased CYP17 function may lead to reduced production of PROG and
17-OHPROG, precursors for the production of cortisol. The increased CYP17 activity
can also lead to an increase in DHEA and A4 production.
To investigate the effects of this increased CYP17 activity seen in the Angora goats, a
model is developed that represents the steroidogenesis in Angora goats. One should be
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able to compare the dynamics of this Angora model with that of the reference ovine
model, and the hypothesis is that the difference is due to an increase in CYP17 activity
only. Therefore the model was not reparameterised with Angora goat experimental
data, to exclude the effects that other parameter values may have on the outcome. The
parameter values of the ovine species were used, and the increased activity of the CYP17
enzyme in the Angora goat was included. To create the Angora model, the CYP17
activity of the ovine model was set to be 2.26 times faster than the 3βHSD activity. The
model is from here on further referred to as the "Angora model", whereas the original
model is still referred to as the "ovine model". The Angora model is first compared to
Angora time course data in literature to determine if it does resemble steroidogenesis in
the Angora goat. Thereafter a comparison of the two models is made by considering the
metabolic control analysis in both systems as well as the results of steady state analysis.
4.3.1 Validation of Angora model against results in literature
In a study by Storbeck et al [105] a single time course for the metabolism of 1 μM PREG
to 17-OHPREG, DHEA, PROG, 17-OHPROG, 16-OHPROG, and A4 in reconstituted
cells for the Angora goat is found. The Angora model is validated by predicting the
outcome of this dataset. In addition to adjusting the activity levels of CYP17 and
3βHSD to that of the Angora goat, a new variable multiplier, δ, is fitted for in the same
way as the other variable multipliers as described on page 58. This multiplier adjusts for
the expression of both CYP17 and 3βHSD (i.e. only the total protein) in the experiment
by Storbeck et al [105]. The value of the multiplier, δ , fitted for is 0.004783.






















Figure 4.17: Time course data and model prediction of the consumption of 1
μM PREG, and the synthesis of 17-OHPROG and A4 in the Angora goat.
Time course data taken from [105]. The 95% confidence intervals of the model simulation
is shown by the grey areas.
Figure 4.17 contains the time course data for the consumption of 1 μM PREG, and
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the synthesis of 17-OHPROG and A4 in the Angora goat as published in [105]. This
figure also shows the predicted outcome of PREG consumption, and 17-OHPROG
and A4 synthesis in this experiment by the Angora model. With the Angora model
prediction of the experiment being very similar to the experimental time course
data it is fair to say that the Angora model, as constructed by simply increasing the
CYP17 activity of the ovine model, is representative of steroidogenesis in the Angora goat.
4.4 Hypocortisolism - comparison of the ovine and
Angora models
The following section shows a comparison of the two models in terms of steady state
and metabolic control analysis and how the difference in the kinetics of steroidogenesis
relates to the symptoms of hypocortisolism.
The steady state concentrations of all steroids of the ovine model and the Angora model
are compared first, as can be seen in Figure 4.18. For this specific steady state simulation,
both models had a constant supply of 0.01 μM/h PREG and the initial concentrations
of all other metabolites were zero. This simulation also includes the removal of A4 at
a constant rate of k times the metabolite concentration where k = 0.1 h-1. The model
at this point in time does not include the conversion of A4 into subsequent metabolites,
therefore this removal of A4 is included in the steady state analysis. This is similar
to the steady state analysis method of the steroidogenic model seen in the study by
Nguyen et al [81]. The ovine model, which represents healthy steroidogenesis, is shown
in green, while the Angora model, with altered adrenal function, is shown in purple
(Fig. 4.18). The Angora model has higher steady state concentrations for DHEA and
A4, while it has lower steady state concentrations for 17-OHPROG than the ovine
model. The steady state concentrations for 17-OHPREG, PROG, and 16-OHPROG
were very similar between the two models. These steady state concentrations show
that an increase in the activity of the CYP17 enzyme alone increases the flux through
the Δ5 pathway, ultimately increasing the synthesis of A4. This increased CYP17 ac-
tivity then also decreases the flux through the branches leading to 17-OHPROG synthesis.
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Figure 4.18: A comparison of the steady state concentrations of 17-OHPREG,
DHEA, A4, PROG, 17-OHPROG, and 16-OHPROG in the ovine and Angora
models. The steady state concentrations were calculated with a constant supply of 0.01
μM/h PREG and a constant removal of A4. The steady state concentrations of DHEA and
A4 are higher in the Angora model, while the ovine model shows has higher steady state
concentrations of 17-OHPROG. Steady state concentrations of PROG, 17-OHPREG, and
16-OHPROG were nearly identical between the two models.
This can also be seen in Figure 4.19, that shows the change in the fluxes to A4 and
17-OHPROG as the CYP17 and 3βHSD enzyme ratio is increased from that of the
ovine model to that of the Angora model. As the CYP17 activity relative to the 3βHSD

















Figure 4.19: The effect of increased CYP17 activity relative to 3βHSD activity
on the fluxes towards A4 and 17-OHPROG. The ratio of the enzyme activities are
varied from that of the ovine model to that of the Angora model, leading to a decreased
flux towards 17-OHPROG and an increased flux towards A4.
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4.4.1 Metabolic control analysis of the ovine and Angora
models
There is a clear difference in the flux through the Δ4 and Δ5 pathways between the
ovine and Angora model (Fig. 4.19). This shift in flux is a result of the increased
CYP17 activity in the Angora model. The next point to investigate is the effect that this
increased CYP17 activity has on the metabolic control of the system. Metabolic control
analysis (MCA), as mentioned on page 37, of the two enzymes, 3βHSD and CYP17, is
shown in Figures 4.21 and 4.22. These figures are heat maps of the control coefficients
of both the ovine and the Angora model shown side by side. Both CYP17 and 3βHSD
catalyses multiple reactions. The effect of each of the enzymes on the flux through the
pathway is considered instead of the effect of each branch of the pathway individually.
Figure 4.21 shows the flux control coefficients of the enzymes on the the flux through the
branches J1 to J11. In Figure 4.20 the branches of the pathway are marked according to
the flux results of Figure 4.21 for easy reference. Figure 4.22 shows the concentration
control coefficients of the enzymes on the concentrations of the metabolites DHEA,
17-OHPREG, 17-OHPROG, PROG, and A4. The MCA was completed with a constant




















Figure 4.20: Partial steroidogenic pathway with the flux through each of the
branches numbered from J1 to J11. Reaction J11 is the constant removal of A4 at
a rate of 0.1 h-1 times the metabolite concentration.
Figure 4.21 shows that both enzymes have fairly similar control over the flux from PREG
to 17-OHPREG (J1) in both the ovine and the Angora model. The control over the flux
from 17-OHPREG to DHEA (J2) is also fairly similar between the ovine and Angora
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models, with 3βHSD having little control and CYP17 having more positive control over
the flux. The results are the same for the flux from DHEA to A4 (J8). There is no
significant change in the control over the flux from PREG to 17-OHPREG to DHEA
to A4 when the activity of the CYP17 enzyme increases from the ovine model to the
Angora model. Figure 4.22 also shows that there is very little change in the control that
the enzymes have on the concentrations of the metabolites 17-OHPREG, DHEA, and
A4 between the two models.
Figure 4.21: Heat map of the flux control coefficients of the enzymes 3βHSD
and CYP17 on the the flux through the branches J1 to J11 as shown in Figure
4.21.
Figure 4.22: Heat map of the concentration control coefficients of the en-
zymes 3βHSD and CYP17 on the concentrations of the metabolites DHEA,
17-OHPREG, 17-OHPROG, PROG, and A4.
There is a change in the flux through the Δ4 pathway between the ovine model and
the Angora model. While 3βHSD has the same control over the flux from PROG to
17-OHPROG (J3) in both the ovine and Angora models, CYP17 has a slightly stronger
negative control over this flux in the Angora model than the negative effect it has in
the ovine model. The change in the control over the flux from 17-OHPROG to A4 (J5)
differs the most between the two models, however the conversion of 17-OHPROG to A4
is so low in both species that this branch is often omitted during modelling [81].
The greatest change in the control over flux is for the conversion of 17-OHPREG to
17-OHPROG (J7), and the conversion of 17-OHPROG to Deoxycortisol (J10) (Fig.
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4.21). The control that 3βHSD and CYP17 have over the fluxes, J7 and J10, in the
ovine model increases once the activity of CYP17 increases to that of the Angora model.
The increased CYP17 activity of the Angora model causes 3βHSD to have a stronger
positive control over both fluxes and CYP17 to have a stronger negative control over
both fluxes. Figure 4.22 show similar results, with neither enzyme having very strong
control over the concentration of 17-OHPROG in the ovine model. Yet, in the Angora
model, 3βHSD has a stronger positive control and CYP17 has a stronger negative control
over the concentration of 17-OHPROG.
The control of both enzymes over the flux from PREG to PROG (J6) also increases,
with similar results seen in Figure 4.22. 3βHSD has a stronger positive control over the
flux J6 and the concentration of PROG in the Angora model than the ovine model,
while CYP17 has a stronger negative control over the flux J6 and the concentration of

































































Figure 4.23: The effect of increased CYP17 activity relative to 3βHSD activity
on the control that the enzymes, CYP17 and 3βHSD, have on the fluxes J1,
J2, J6 and J7.
The changes in the flux controls between the two models are apparent in Figure 4.21,
however, the quantitative changes in the system between the two models are not
immediately clear. To investigate the shift in control over the fluxes of the Δ4 and Δ5
branches between the two models, we consider the flux pairs J1 and J6, as well as J2
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and J7. These two splits in the pathway play an important role in the relative synthesis
of 17-OHPROG and A4. Figure 4.23 shows the changes in the control that CYP17 and
3βHSD have on the fluxes J1, J2, J6 and J7. For both enzymes the change in the control
over J6 and J7 is greater than the change in control over J1 and J2 as the enzyme
activity is varied from the ration seen in the ovine model to the ratio of the Angora model.
To quantify these differences between the two models, we consider the ratio of the change
in the flux control of J1 and J6, as well as that of J2 and J7, of both enzymes (see Table
4.9). The change in the control over J6 is more than the change in the control over J1
between the two models for both enzymes. Similar results are seen for the change in the
control over J2 and J7, with the change in the control over J7 being higher. For both
enzymes, the changes in the control over the fluxes leading to the Δ4 branches (J6 and
J7) is higher than the changes in the control over the fluxes of the Δ5 branches (J1 and
J2). The ratio of the change in flux control over J1 to the flux control over J6 (ΔCJ1
: ΔCJ6) is very similar between CYP17 and 3βHSD, and so also the ΔCJ2 : ΔCJ7 of
CYP17 and 3βHSD. There is however a difference in the flux control ratios for the split
in the pathway at J1 and J6, and the split at J2 and J7. The difference between ΔCJ1 :
ΔCJ6 and ΔCJ2 : ΔCJ7 is also fairly similar for both enzymes.
Table 4.9: Flux control ratios. These changes are the change in control over the fluxes
between the ovine and the Angora models.
CYP17 3βHSD
ΔCJ1 : ΔCJ6 ΔCJ1 : ΔCJ6
1 : 2.13 1 : 2.60
ΔCJ2 : ΔCJ7 ΔCJ2 : ΔCJ7
1 : 5.19 1 : 5.51
Taken together, the shift in control between the ovine model and the Angora model is
clear at both the J1 and J6, as well as the J2 and J7 split in the pathway, however,
the shift in control is more prominent at the J2 and J7 split. From this one can
deduce that there is not one single point in the pathway that is responsible for the
shift in flux from 17-OHPROG synthesis to A4 synthesis as the CYP17 activity increases.
The following section contains the results of simulating a cold stress response with both
the ovine and the Angora models.
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4.4.2 Simulating the physiological stress response
The physiological response to cold stress is simulated and the differences in behaviour
between the ovine and Angora model is considered. To simulate this response the
concentration of PREG is increased, whereafter the steady state concentrations and
changes in flux through the two models are compared.
The ratio of cortisol precursor, 17-OHPROG, and sex steroid precursor, A4 at varying
concentrations of PREG is shown in Figure 4.24. With an increased concentration of
PREG in the system, both models show that the synthesis of 17-OHPROG relative
to A4 increases. This corresponds to the physiological response where physiological
stress induces an increase in cortisol synthesis. Both models show that this response
is triggered. In the ovine model, as PREG increases, the synthesis of 17-OHPROG
relative to A4 increases, with more 17-OHPROG than A4 being synthesised once the
concentration of PREG in the system is more than 0.2 uM. However, this response is
much weaker in the Angora model. With increased PREG concentration, the synthesis
of 17-OHPROG also increases, with the synthesis thereof only exceeding the synthesis
of A4 once a PREG concentration of 2 uM is reached. A much stronger stress response
is therefore needed for the Angora model to induce the same cortisol synthesis from
increased 17-OHPROG seen in the ovine model.






















Figure 4.24: The difference in the ratio of steady state concentrations of 17-
OHPROG and A4 with increased PREG concentration between the ovine
model and Angora model.
Figure 4.25 shows the differences in the ratios of the fluxes, J1 and J6, and J2 and J7
(4.20) between the Angora and ovine models when the PREG concentration is varied. At
lower PREG concentrations the flux J1 is much higher than the flux J6 in both models,
however this ratio is higher in the Angora model than in the ovine model. Similar quali-
tative results are seen with the ratio of J2 and J7. As the PREG concentration increases,
simulating the stress response in the animals, these ratios decrease, indicating that the
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flux shifts from the Δ5 pathway more towards the Δ4 pathway in both models. Figure
4.25 shows that both species respond to the stress response by shifting the flux towards
the synthesis of cortisol, this response is however much stronger in the ovine model.
This also suggests that the Δ5 pathway is favoured in the Angora species as the fluxes
J1 and J2 is higher than the fluxes of the Δ4 pathway, even at high PREG concentrations.



























Figure 4.25: The differences in the ratio of the fluxes J1 and J6 and the ratio
of the fluxes J2 and J7 between the Angora and ovine models with increased
PREG concentration.
Taken together, with 17-OHPROG being a precursor for the synthesis of cortisol, the
results of the steady state analysis and the MCA analysis support the hypothesis that
the hypocortisolism seen in the Angora goats can be caused by increased CYP17 activity
relative to 3βHSD activity. This is caused by the increased flux through the Δ5 pathway,
leading to increased A4 synthesis and reduced 17-OHPROG synthesis, causing a decrease
in the synthesis of cortisol. As shown previously with the changes in the flux control
ratios, both points in the pathway, where there is a split towards either the Δ4 or Δ5
pathways, contribute to the hypocortisolism in Angora goats. The point where PREG
is either converted to PROG or 17-OHPREG is a point where the control of both the
CYP17 and 3βHSD enzymes are increased in the Angora model. Similar results are seen
at the point where 17-OHPREG is either converted to DHEA or 17-OHPROG, however,
the change in the control at this point is even larger between the ovine and Angora mod-
els. The change in activity has little effect on the control over the Δ5 branches, but has
a great effect on the control over the branches leading to cortisol synthesis. This altered
enzyme activity in the Angora model, reduces the flux towards cortisol precursors, and
an increased flux towards the sex steroid precursors. The Angora model does respond
to the simulated cold stress, however, this response is much lower than the response
seen in the ovine model, maintaining a high flux through the Δ5 branches of the pathway.
To consider the impact that these differences have on physiological level: the hypocor-
tisolism in Angora goats are not necessarily caused by an increase in the synthesis of
sex steroids, resulting in decreased cortisol synthesis, but rather a poor response to
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physiological stress leading to reduced cortisol synthesis which then leads to increased
sex steroid synthesis.
4.4.3 Treatment strategies
The levels of cortisol in the system regulates the blood glucose level of an animal.
The current treatment administered to the young goats, in an attempt to boost their
blood glucose levels, is either glucose enriched food or an intravenous dose of glucose
[123, 124]. In addition to these treatments, the effect of cortisol treatments have also
been investigated. It was however found that constant hypodermic treatment of young
Angora goats with cortisol resulted in reduced mohair production in comparison with
a control group [43]. The administering of glucose is therefore the only preventative
method that can be used against hypocortisolism related deaths in Angora goats. As
far as reducing the prevalence of hypocortisolism in the Angora goat species goes, the
current approach is selective breeding trials with the aim of breeding a more hardy
population without the loss of quality mohair production [107].
Conclusion
The ability to survive physiological stress is dependent on the levels of cortisol in
the system. The low cortisol and high sex steroid precursor production seen in the
South African Angora goat is most likely caused by decades of inbreeding to improve
mohair quality. The development of this trade-off trait between the steroids along with
improved mohair quality through the years would suggest that a high level of sex steroid
production is needed to ensure the production of high quality mohair. This phenomenon
is not seen in any Angora goat flocks in other parts of the world. The quality of mohair
produced in countries such as Turkey, India, Albania, Russia, and the USA are inferior to
South African mohair and there is no evidence of hypocortisolism among those Angora
goat flocks [12, 26]. It is possible that the hypocortisolism is not just an unfortunate side
effect of inbreeding, but a necessary trait for the production of superior quality mohair.
In this chapter two models were developed and validated: one for a control species with
healthy steroidogenic function and one for the the Angora goat suffering from altered
adrenal function. MCA showed that the increased CYP17 activity in the Angora goat
changes the control that both CYP17 and 3βHSD have on the steroidogenic flux through
the system. It was also found that the shift in steroidogenic flux from 17-OHPROG to
A4 as enzyme activity is varied from the ovine model ratio to the Angora model ratio
cannot be pin pointed to only one branch in the pathway. The point of conversion
80
Stellenbosch University https://scholar.sun.ac.za
4.4. Hypocortisolism - comparison of the ovine and Angora models
of PREG to either PROG or 17-OHPREG and even more so the point of conversion
of 17-OHPREG to either DHEA or 17-OHPROG are splits in the pathway where the
steroid flux is diverted through either the Δ4 or Δ5 branches of the pathway. The
response to cold stress by both models were then simulated and again it could be seen
that these two splits in the pathway behave similarly when diverting steroid flux. A
delayed response to PREG supply is seen at both of these points in the pathway. From
this one can conclude that the Δ5 pathway is the preferred pathway in the Angora goat,
even with a simulated stress response, and that both the PREG and 17-OHPREG split





Modelling the 5α and 5β reduction of
11-Ketotestosterone in the liver
In recent years it has been shown that 11-Ketotestosterone (11KT) is a potent androgen
playing a key role in androgen dependent diseases, such as polycystic ovary syndrome
(PCOS), castration resistant prostate cancer (CRPC), and congenital adrenal hyperpla-
sia (CAH) [87, 108]. Having gone largely unnoticed, 11KT might be a more prominent
androgen in women than previously thought. Unlike testosterone (T), 11KT does not
decrease with age and has been shown to be prevalent androgen in PCOS [77, 87]. With
the importance of 11-oxygenated androgens only recently being discovered, further study
thereof is necessary.
11KT and T can either be 5α or 5β reduced. 5α reduction can be catalysed by SRD5A1
and SRD5A2, while 5β reduction is catalysed by AKR1D1 [11, 70]. The 5α reduction
products or androgens are synonymous with increased androgenic activity, while the 5β
reduction products are not known to show androgenic activity [112]. As such, studying
the ratio of relative conversion of 11KT and T to either their 5α or 5β reduced prod-
ucts is of importance as the one product shows androgenic activity and the other does not.
The enzymes, AKR1D1, SRD5A1, and SRD5A2 are expressed in the liver [113–115]
where they compete for the substrates, T, A4, 11KT, and 11-Ketoandrostenedione
(11KA4). This chapter shows the development of a model to simulate the interaction
between these three enzymes in the liver, ultimately showing whether the 5α or 5β
reduction of substrates are the predominant process. The activity of AKR1D1, SRD5A1,
and SRD5A2 towards the classic androgens, A4 and T, and the 11-oxygenated androgens,
11KA4 and 11KT, are characterised.
This chapter contains the model construction and parameterisation with kinetic data of
transfected cells. The identifiability of the parameter values are tested and the model




expression levels of these enzymes are included in the model, whereafter the model
is studied under physiological steady state conditions. The model shows that the 5β
reduction of 11KT is the preferred process in the liver.
5.1 Experimental data
The experimental data used for the construction of this model were collected by Lise
Barnard at the Stellenbosch University. As the main focus of this chapter is the
construction and further analysis of the 5α and 5β reduction model in the liver, the
in depth details regarding the experimental procedure is not discussed. The detailed
experimental procedure can be found in her PhD thesis and the unpublished manuscript
attached in Appendix B. Experimental data were collected with the use of two sets of
transfected cells. For each of the enzymes, AKR1D1, SRD5A1, and SRD5A2, two sets of
experimental data were collected, one set from each transfection. The datasets collected
from the two transfections differ in enzyme concentration and time range (12 and 24
hours). The data collected over 12 hours were used for model parameterisation while the
data collected over a period of 24 hours were used for model validation.
5.2 Model parameterisation
The initial conditions of the experimental datasets used for model parameterisation are
as follows: T (0.1 μM and 1.0 μM), 11KT (0.1 μM and 1.0 μM), A4 (0.1 μM, 1.0 μM,
and 10.0 μM), and 11KA4 (0.1 μM, 1.0 μM, and 10.0 μM), for each of the three enzymes,
AKR1D1, SRD5A1, and SRD5A2. The reactions, as catalysed by either one of the
enzymes, are numbered from v1 to v12 in Figure 5.1. The enzyme AKR1D1 catalyses 5β
reduction reactions v3, v6, v9, and v12. SRD5A1 catalyses 5α reduction reactions v1, v4,
v7, and v10, while SRD5A2 catalyses the 5α reduction reactions v2, v5, v8, and v11. The
5α reduction products of the substrates A4, T, 11KA, and 11KT are 5αDione, 5αDHT,
11K5αDione, and 11K5αDHT respectively, while the 5β reduction products are 5βDione,
5βDHT, 11K5βDione, and 11K5βDHT respectively. The corresponding rate equations
for these reactions, used during model parameterisation, are shown as equations 5.1
to 5.4. These rate equations depict the irreversible Michaelis-Menten kinetics of the
enzymes, while the ordinary differential equations 5.5a to 5.5l depict the change in
metabolite concentration over time. This ODE based model is fitted to the experimental
data with nonlinear regression to determine the solutions for the parameters V max1 to
V max12, and Km1 to Km12. Fitting of the model to the data is done by minimising the
objective function 5.6, which is the weighted SSR value between the model and the data.




performed in triplicate, thus the SSR is weighted to the variance in the experimental
data (σ2i ). The functions objectiveFunction and minimizeObjectiveFunction of the
novel Mathematica add-on package IdentifiabilityAnalysis was used to determine
the parameters values and their respective confidence intervals. The solutions for the
parameter values are shown in Table 5.1. The model fit to the experimental data are





























Figure 5.1: Reactions v1 to v12, as catalysed by either AKR1D1, SRD5A1 or
SRD5A2 with A4, T, 11KA4 or 11KT as substrate.
5.2.1 Rate equations
vi =
V maxi · [A4]
Kmi + [A4]
i = 1, 2, 3 (5.1)
vj =
V maxj · [T ]
Kmj + [T ]
j = 4, 5, 6 (5.2)
vk =
V maxk · [11KA4]
Kmk + [11KA4]
k = 7, 8, 9 (5.3)
vl =
V maxl · [11KT ]
Kml + [11KT ]




5.2.2 Ordinary differential equations
d
dt
[A4] = −v1 − v2 − v3 (5.5a)
d
dt
[5αDione] = v1 + v2 (5.5b)
d
dt
[5βDione] = v3 (5.5c)
d
dt
[T ] = −v4 − v5 − v6 (5.5d)
d
dt
[5αDHT ] = v4 + v5 (5.5e)
d
dt
[5βDHT ] = v6 (5.5f)
d
dt
[11KA4] = −v7 − v8 − v9 (5.5g)
d
dt
[11K5αDione] = v7 + v8 (5.5h)
d
dt
[11K5βDione] = v9 (5.5i)
d
dt
[11KT ] = −v10 − v11 − v12 (5.5j)
d
dt
[11K5αDHT ] = v10 + v11 (5.5k)
d
dt








where n is the number of experimental datasets, datai is the experimental data, modeli is
the model fit to datai and σ2i is the variance in the experimental data. During nonlinear





Table 5.1: Parameter values with their respective 95% confidence intervals shown in
brackets.
Parameter μM/h Parameter μM
Vmax A4AKR1D1 0.029 (0.027 - 0.031) Km A4AKR1D1 0.068 (0.052 - 0.086)
Vmax 11KA4AKR1D1 0.289 (0.211 - 0.374) Km 11KA4AKR1D1 0.772 (0.454 - 1.161)
Vmax TAKR1D1 0.023 (0.015 - 0.032) Km TAKR1D1 0.097 (0.048 - 0.168)
Vmax 11KTAKR1D1 0.374 (0.279 - 0.566) Km 11KTAKR1D1 4.09 (2.98 - 6.34)
Vmax A4SRD5A1 2.57 (1.22 - 5.13) Km A4SRD5A1 7.77 (3.28 - 15.5)
Vmax 11KA4SRD5A1 1.208 (0.913 - 1.741) Km 11KA4SRD5A1 15.58 (11.11 - 23.6)
Vmax TSRD5A1 0.067 (0.047 - 0.102) Km TSRD5A1 0.547 (0.329 - 0.985)
Vmax 11KTSRD5A1 0.007 (0.004 - 0.014) Km 11KTSRD5A1 0.635 (0.232 - 1.27)
Vmax A4SRD5A2 0.254 (0.241 - 0.267) Km A4SRD5A2 0.271 (0.234 - 0.309)
Vmax 11KA4SRD5A2 0.249 (0.183 - 0.354) Km 11KA4SRD5A2 0.437 (0.252 - 0.737)
Vmax TSRD5A2 0.218 (0.195 - 0.249) Km TSRD5A2 0.205 (0.168 - 0.254)























T → 5βDHT via AKR1D1


















11KT → 11K5βDHT via AKR1D1
(c) (d)


















A4 → 5βDione via AKR1D1


















11KA4 → 11K5βDione via AKR1D1
Figure 5.2: Conversions of T to 5βDHT (a), 11KT to 11K5βDHT (b), A4 to
5βDione (c), and 11KA4 to 11K5βDione (d) by AKR1D1. Data points are shown
with their respective standard error bars. The model fits are shown as the solid lines with























T → 5αDHT via SRD5A1


















11KT → 11K5αDHT via SRD5A1
(c) (d)


















A4 → 5αDione via SRD5A1


















11KA4 → 11K5αDione via SRD5A1
Figure 5.3: Conversions of T to 5αDHT (a), 11KT to 11K5αDHT (b), A4 to
5αDione (c), and 11KA4 to 11K5αDione (d) by SRD5A1. Data points are shown
with their respective standard error bars. The model fits are shown as the solid lines with























T → 5αDHT via SRD5A2


















11KT → 11K5αDHT via SRD5A2
(c) (d)


















A4 → 5αDione via SRD5A2


















11KA4 → 11K5αDione via SRD5A2
Figure 5.4: Conversions of T to 5αDHT (a), 11KT to 11K5αDHT (b), A4 to
5αDione (c), and 11KA4 to 11K5αDione (d) by SRD5A2. Data points are shown
with their respective standard error bars. The model fits are shown as the solid lines with





The identifiability of all the parameter values were tested. The likelihood ratio test
was used to create profile likelihood plots and determine the 95% confidence intervals
as well as whether the parameter values are identifiable [51, 89]. The profile likelihood
values are indicated by the solid black lines in the profile likelihood plots. The 95% Chi-
squared distribution value is indicated by the solid red threshold line on the plots. The
optimal parameter value solution, as determined during model fitting, is indicated by the
dashed blue line. The parameter value is enclosed within the 95% confidence interval, as
shown by the solid blue lines. These confidence intervals represent the value where the
profile likelihood of the parameter intercepts the 95% Chi-squared threshold. All of the
estimated values were identifiable except for the Vmax and Km values for the conversion of
11KT to 11K5αDHT, and A4 to 5αDione by SRD5A1. These values were practically non-
identifiable, with a 95% confidence interval that is lower bounded, but not upper bounded.
For these non-identifiable parameters a value of two times the parameter value was used
as the upper limit of the confidence interval. The profile likelihood plots of the parameters
are included at the end of this document in Appendix B. These profile likelihood plots
were created with the functions profileLikelihood and likelihoodRatioPlot of the
Mathematica add-on package IdentifiabilityAnalysis, see chapter 3.
5.4 Model validation
The parameter value estimations were validated by using the model to predict the
outcome of the experiments completed with another transfection. The initial conditions
of the experimental datasets used for model validation are as follows: T (0.1 μM, 1.0 μM,
and 10.0 μM) and 11KT (0.1 μM, 1.0 μM, and 10.0 μM), for each of the three enzymes,
AKR1D1, SRD5A1, and SRD5A2. A variable multiplier was fitted for to account for the
transfection efficiency of each of the enzymes. The variable multiplier values fitted for
for each of the enzymes are 1.55, 2.34, and 0.667 for AKR1D1, SRD5A1, and SRD5A2
respectively. Only one multiplier value was fitted for per enzyme for both the T and
11KT substrate conversions during the prediction of the experimental time course data.
These multipliers correct for the relative levels of enzyme expression and is included
as such in the rate equations, while all parameter values were kept fixed. The model
predictions of the validation data are shown in Figure 5.5. These variable multipliers
only adjust for the transfection efficiency and are used, along with the determined V max
and Km values of each enzyme to predict the validation datasets.
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T → 5βDHT via AKR1D1


















11KT → 11K5βDHT via AKR1D1


















T → 5αDHT via SRD5A1


















11KT → 11K5αDHT via SRD5A1


















T → 5αDHT via SRD5A2


















11KT → 11K5αDHT via SRD5A2
Figure 5.5: Validation of newly determined AKR1D1, SRD5A1, and SRD5A2
parameter values. Model predictions (solid lines) of the experimental data (points) are
shown.
5.5 Modelling of AKR1D1, SRD5A1 and SRD5A2
kinetics with 1:1:1 enzme expression
The parameter values of AKR1D1, SRD5A1, and SRD5A2, as shown in Table 5.1, were
used to construct a model which describes equal expression of the three enzymes (in
a ratio of 1:1:1). This undetermined model can be used to simulate the conversion of
any initial concentrations of T, A4, 11KT, and/or 11KA4 at any expression levels of
the enzymes AKR1D1, SRD5A1, and SRD5A2. In addition to the parameters listed in
Table 5.1, three parameters were added to the model. The three parameters (AKR1D1exp,
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SRD5A1exp, and SRD5A2exp), which represent the expression levels of the three enzymes,
allows one to change the enzyme expression levels to any desired values.
Experimental results of mixing of the transfected enzymes in a 1:1 volume ratio were
predicted with the model as validation thereof. It is assumed that the transfection
efficiencies of the transfected enzymes are similar. With the same initial concentrations
under which the experimental data were collected, model predictions of the experimental
results were simulated. These model predictions and experimental results can be seen
in Figures 5.6 and 5.7. AKR1D1 was mixed in a ratio of 1:1 with either SRD5A1 or
SRD5A2. The conversion of 1 μM T, 11KT, A4 or 11KA4 to their respective products





















































































































Figure 5.6: Model prediction of the experimental results of 1:1 mixing of
AKR1D1 with SRD5A1. The conversion of 1 μM T, 11KT, A4 or 11KA4 were
measured after 24 hours.
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Figure 5.7: Model prediction of the experimental results of 1:1 mixing of
AKR1D1 with SRD5A2. The conversion of 1 μM T, 11KT, A4 or 11KA4 were
measured after 24 hours.
Figure 5.8 shows the change in enzyme activities with variation in T and 11KT
concentration. The activity of SRD5A2 is the highest of the three enzymes at all
concentrations of 11KT. SRD5A1 has the highest affinity for 11KT, but has a very low
maximal rate. AKR1D1 and SRD5A2 have similar affinities for 11KT, however SRD5A2
has a higher maximal rate, resulting in SRD5A2 having a higher catalytic efficiency
(Vmax/Km) towards 11KT than AKR1D1. With T as substrate, SRD5A2 again has the
highest activity at all concentrations of T. At lower concentrations of T (up to 0.15 μM)
AKR1D1 has higher activity than SRD5A1, however, above that threshold, the activity
of SRD5A1 is higher. When considering the catalytic efficiencies of the enzymes with
T as substrate, the efficiency of SRD5A2 is the highest, with a value of 1.063, followed
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Figure 5.8: Activities of AKR1D1, SRD5A1, and SRD5A2 with variation of
substrate (11KT and T) concentration.
5.6 Modeling of AKR1D1, SRD5A1 and SRD5A2
kinetics in the liver
To simulate the physiological expression of AKR1D1, SRD5A1, and SRD5A2 in the
liver, the relative RNA expression of these enzymes were used. The absolute values of
255.7 [113], 16.3 [114] and 34.2 [115] tags per million, as recorded on the The Human
Protein Atlas database were used. A limitation of using the RNA expression levels
of these enzymes as an indicator for the protein expression levels is that the relative
RNA levels do not always necessarily relate to the relative enzyme expression levels.
At this point these were the most accurate data available. The parameters AKR1D1exp,
SRD5A1exp, and SRD5A2exp were set to the scaled, relative values of 15.7, 1, and 2.10 for
AKR1D1, SRD5A1, and SRD5A2 respectively.
Figure 5.9 shows model simulations of the conversion of 0.8 nM 11KT to 11K5αDHT
and 11K5βDHT, and 0.8 nM T to 5αDHT and 5βDHT at enzyme expression levels of
1:1:1 in comparison to physiological enzyme expression levels. As experimental data of
the synthesis of the 5α and 5β reduction products of the substrates 11KT, 11KA4, T,
and A4 with physiological enzyme expression levels has not yet been collected, model
simulations can be used to predict the relative synthesis of these products. The initial
concentrations of 0.8 nM are close to physiological plasma concentrations of T and 11KT
94
Stellenbosch University https://scholar.sun.ac.za
5.6. Modeling of AKR1D1, SRD5A1 and SRD5A2 kinetics in the liver
[52]. At enzyme expression levels in the ratio 1:1:1 the 5α reduction of both T and 11KT
is the preferred reaction. With T as substrate, being fully converted to either 5αDHT
or 5βDHT, the majority of T is converted to 5αDHT (83.4%) with only 16.6% of T
being converted to 5βDHT. Although the 5α reduction product is also the predominant
product formed with 11KT as substrate, more of the 5β reduction product is formed than
with T as substrate, with 65.9% 11K5αDHT and 34.1% 11K5βDHT being synthesised.
This is however not the case at physiological expression levels of these enzymes. As the
physiological expression level of AKR1D1 is higher than that of SRD5A1 and SRD5A2,
the 5β reduction of both T and 11KT are preferred. If all T substrate is fully converted
to 5αDHT and 5βDHT, about 38.8% of T is converted to 5αDHT and about 61.2%
T is converted to 5βDHT. With 11KT as substrate much more of the 5β reduction
product, 5βDHT, is synthesised (80.0%), while less of the 5α reduction product, 5αDHT,
is synthesised (20.0%). Similar qualitative results are seen for the conversion of 11KA4









































































































5α and 5β reduction of A4
Figure 5.9: Model simulations of the conversion of 0.8 nM 11KT, T, 11KA4 or
A4 to their respective 5α and 5β reduction products at 1:1:1 enzyme expression (white)
and physiological enzyme expression levels (gray).
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5.6.1 Steady state analysis with T and 11KT as substrates
The dynamics of the model under the following steady state conditions were studied: a
constant inflow of 0.0720 μM/h and 0.0648 μM/h 11KT into the liver for men and women
respectively and a constant inflow of T into the liver of 1.419 μM/h for men and 0.0632
μM/h for women. This is calculated from the plasma levels of 234 pg/mL 11KT and
4548 pg/mL T in men and 250 pg/mL 11KT and 225 pg/mL T in women [52] and liver
perfusion rates of 1.35 L/min in women and 1.5 L/min in men [60]. The degradation of
steroid products or removal thereof by the system is included in the model as 0.1 min-1
times the steroid concentration, similar to the steroid hormone modelling techniques
used by Nguyen et al [81]. Only the initial 5α or 5β reduction of the steroid hormones
are considered and no further conversion of the 5α and 5β products.
The change in steady state concentrations of the 5α and 5β reduction products
11K5αDHT, 11K5βDHT, 5αDHT, and 5βDHT with the variation in AKR1D1 expression
relative to SRD5A1 and SRD5A2 expression can be seen in Figure 5.10. Under these
steady state conditions, which were chosen to resemble a physiological steady state, the
5β reduction of 11KT is the preferred reaction once AKR1D1 is expressed in the liver at
a ratio of 2:1:1 or higher relative to SRD5A1 and SRD5A2, while the 5β reduction of T
is only preferred once that ratio is 5:1:1 or higher.
























































Figure 5.10: Variation in steady state concentrations of 11K5αDHT,
11K5βDHT, 5αDHT, and 5βDHT as the relative expression of AKR1D1 to
SRD5A1 and SRD5A2 changes.
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The metabolites T, 11KT, A4, and 11KA4 are pooled in vivo and the enzymes AKR1D1,
SRD5A1, and SRD5A2 compete for the same pooled substrates. The plasma levels of T
in men are higher than in women, which not only influences the synthesis of 5αDHT and
5βDHT, but also that of 11K5αDHT and 11K5βDHT. This large difference in T plasma
levels has little effect on the synthesis of 5αDHT relative to 5βDHT, and the synthesis
of 11K5αDHT relative to 11K5βDHT. In both men and women 5αDHT and 5βDHT are
synthesised in a ratio of approximately 1:1.75, while 11K5αDHT and 11K5βDHT are
synthesised in a ratio of approximately 1:4. The absolute values of the steroid hormones
do however differ between men and women, but this is expected due to the much higher
levels of T in men. As shown previously, the 5β reduction of 11KT is the preferred
reaction with physiological enzyme expression levels. Steady state concentrations of
the metabolites 11K5αDHT, 11K5βDHT, 5αDHT, and 5βDHT for men and women are









































































































T metabolism in the liver (Women)
Figure 5.11: Model simulation of the steady state concentrations of 11K5αDHT,
11K5βDHT, 5αDHT, and 5βDHT in the liver with physiological expression
of AKR1D1, SRD5A1, and SRD5A2 (15.7:1:2.1).
Conclusion
Knowing the relative conversion of androgens such as T, 11KT, A4, and 11KA4 to their
respective 5α and 5β reduction products is of importance, as the 5α reduction products
show strong androgenic activity, while the 5β reduction products do not. The enzymes
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5.6. Modeling of AKR1D1, SRD5A1 and SRD5A2 kinetics in the liver
AKR1D1, SRD5A1, and SRD5A2 are expressed in the liver, with AKR1D1 catalysing
the 5β reduction of androgens and SRD5A1 and SRD5A2 catalysing the 5α reduction of
androgens. These enzymes compete for the same substrates and have different expression
levels. The enzymes also have different efficacies for the androgen substrates. It is
therefore useful to have a mathematical model which describe these enzyme dynamics
and the relative synthesis of 5α and 5β reduction products. We created a model that
can simulate these steroid conversions in the liver. The model was parameterised with
experimental data form reconstituted cells, whereafter it was validated with experimental
data obtained from mixing cells expressing AKR1D1 and cells expressing either SRD5A2
or SRD5A2. The model has been constructed such that the steroid conversion, given
any rate of androgen inflow into the liver, at any levels of enzyme expression can be
simulated. We studied the specific case of the model, where the enzymes are expressed
in the physiological ratio and see that the 5β reduction of 11KT is the predominant
reaction in the liver. Similarly, the 5β reduction of the other androgens are also the




Computational modelling of the
intratumoral androgen metabolism in
castration resistant prostate cancer
Prostate cancer is one of the most prevalent forms of cancer in men. Androgen
deprivation therapy via chemical or physical castration is the current treatment for
prostate cancer. Despite this treatment castration resistant prostate cancer (CRPC)
often emerges [22, 98]. Prostate cancer cells express enzymes that convert androgen
precursors from the adrenal glands to potent androgens [45].
Under healthy conditions A4 is converted to T via AKR1C3 which is in turn converted
to 5αDHT via SRD5A (see Figure 6.1). T can also be converted back to A4 via
17βHSD2. Androgen depravation therapy significantly lowers the amount of T in
circulation, therefore limiting the synthesis of potent 5αDHT. What is seen with the
emergence of CRPC is that 5αDHT is synthesised from A4 with 5αDione as intermediate;
A4 is converted to 5αDione via SRD5A and 5αDione is in turn converted to 5αDHT
via AKR1C3. 17βHSD2 can also convert 5αDHT back to 5αDione. The synthesis of
5αDHT with 5αDione as intermediate is known as the alternate 5αDione pathway. This
pathway is however not the only source of androgens for CRPC. It has been found
that 11β-hydroxyandrostenedione (11OHA4) is a precursor for the potent androgens
11KT and 11K5αDHT, see Figure 6.2, this pathways is known as the 11OHA4 pathway.
11K5αDHT is equipotent to 5αDHT as a substrate for the enzymes in prostate cancer
cells. It was also found that 11KA4 and 11K5αDione are better substrates for AKR1C3
than A4 or 5αDione [7]. The 11OHA4 pathway has not yet been studied in as much
detail as the classic androgen pathway or the 5αDione pathway. The same enzymes are




The classic androgens and the 11-oxygenated androgens are pooled within the CRPC
tumors, where the enzymes can catalyse either the reactions of the 5αDione or the
11OHA4 pathway. Due to the multi-functionality of these enzymes and the different
effects of the classic and the 11-oxygenated androgens, it is of importance to determine
the relative contribution of the classic and 11-oxygenated androgens to the combined
androgen pool.
In an attempt to predict the contribution of either group of androgens to the androgen
pool, we have constructed a model that describes the dynamics of the 5αDione biosyn-
thesis pathway as shown in Figure 6.1 and the dynamics of the 11-oxygenated androgen
biosynthesis pathway as shown in Figure 6.2 in CRPC C42B cells. The combined
dynamics of the AKR1C3 and 17βHSD2 enzymes have previously been parameterised,
these values will be taken from literature [7]. All data used in this chapter for model
construction and validation were collected by Prof Storbeck and members of his group at
Stellenbosch University, including the data published in [7]. The SRD5A data have pre-
viously been analysed by our group and the dynamics thereof have been parameterised.
These unpublished results will be used as the parameter values for SRD5A.
The dynamics of the 11βHSD2 and 3αHSD enzymes are parameterised and validated
in this chapter and these newly determined parameter values are used along with
the other, previously determined parameter values, to construct the model. The
parameter values for the kinetics of 11βHSD2 are determined from time course data of
transfection experiments. No kinetic data for the reactions catalysed by 3αHSD have
been collected, therefore, the experimental data from C42B prostate cancer cells have
been used to fit for and validate the 3αHSD parameters. Metabolic control analysis
identifies the enzymes with most control over hormone flux through the system. The
effect of increased expression of the enzymes on the steady state concentrations of
the metabolites are investigated. Lastly, steady state analysis of the model shows the














Figure 6.1: Schematic representation of the classic androgen (A4 to 5αDHT


















6.1. Previously determined parameter values
6.1 Previously determined parameter values
The parameter values for the enzymes AKR1C3, 17βHSD2 [7], and SRD5A have
previously been determined (unpublished results) and were used as is in all further
analyses (values shown in Tables 6.1 to 6.3).
Table 6.1: Parameter values for AKR1C3 kinetics with their respective 95% confi-
dence intervals shown in brackets.
Substrate Vmax (μM/h) Km (μM)
11KA4 0.27 (0.25 - 0.30) 0.11 (0.07 - 0.13)
11K5αDione 0.55 (0.44 - 0.72) 0.23 (0.16 - 0.33)
11KAST 0.59 (0.48 - 0.78) 0.34 (0.24 - 0.50)
A4 0.02 (0.01 - 0.02) 0.06 (0.03 - 0.09)
5αDione 0.01 (0.01 - 0.02) 0.12 (0.08 - 0.20)
AST 0.05 (0.04 - 0.08) 0.27 (0.14 - 0.55)
Table 6.2: Parameter values for 17βHSD2 kinetics with their respective 95% confi-
dence intervals shown in brackets.
Substrate Vmax (μM/h) Km (μM)
T 3.71 (3.41 - 4.04) 5.08 (4.56 - 5.67)
5αDHT 2.25 (2.07 - 2.44) 3.77 (3.40 - 4.17)
3αAdiol 3.99 (3.49 - 4.57) 5.86 (4.94 - 7.03)
11KT 4.35 (4.01 - 4.73) 9.11 (8.24 - 10.12)
11K5αDHT 6.40 (5.70 - 7.23) 7.72 (6.67 - 9.02)
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Table 6.3: Parameter values for SRD5A kinetics with their respective 95% confi-
dence intervals shown in brackets.
Substrate Vmax (μM/h) Km (μM)
A4 0.0066 (0.0058 - 0.0079) 12.1 (9.97 - 14.76)
T 0.0936 (0.0414 - 0.187) 373 (157 - 762)
11OHA4 0.00378 (0.0031 - 0.0047) 30.4 (24.1 - 40.1)
11KA4 0.0156 (0.0078 - 0.0318) 90.7 (41.2 - 187)
11KT 0.021 (0.003 - 0.042) 918 (118 - 1847)
6.2 Newly determined parameter values
6.2.1 11βHSD2
The 11βHSD2 experimental data, used for parameterisation, were collected from trans-
fected cells with only 11βHSD2 present. Varying initial concentrations of either 11OHA4,
11β-Hydroxy-5α-Dione (11OH5αDione), or 11β-Hydroxyandrosterone (11OHAST) were
converted to the products 11KA4, 11K5αDione, or 11-Keto-androsterone (11KAST) re-
spectively. The initial concentrations were 0.25, 0.5, 0.75, 1.0, 2.5, and 5.0 μM, and all
experiments were performed in triplicate.
6.2.1.1 Parameter estimation
Irreversible Michaelis-Menten kinetics were assumed and the rate equations for the
reactions catalysed by 11βHSD2 are shown as equations 6.1 to 6.3. The conversion of
11OHA4 to 11KA4 is reaction v1, the conversion of 11OH5αDione to 11K5αDione is
reaction v2, and the conversion of 11OHAST to 11KAST is reaction v3. The ordinary
differential equations 6.4a to 6.4f show the change in metabolite concentrations over
time. This ODE based model is fitted to the experimental data and the respective Vmax
and Km values are determined by minimising the objective function 6.5. The function
minimizeObjectiveFunction of the package IdentifiabilityAnalysis was used for
model fitting. All experiments were performed in triplicate and the objective function
is weighted to the variance in the experimental data. Table 6.4 shows the parameter
estimations with confidence intervals for the enzyme 11βHSD2. Figure 6.3 shows the
experimental data and model fits.
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Rate equations
v1 =








V max11OHAST · [11OHAST ]





[11OHA4] = −v1 (6.4a)
d
dt
[11OH5αDione] = −v2 (6.4b)
d
dt
[11OHAST ] = −v3 (6.4c)
d
dt
[11KA4] = v1 (6.4d)
d
dt
[11K5αDione] = v2 (6.4e)
d
dt








where n is the number of experimental datasets, datai is the experimental data, modeli
is the model fit to datai and σ2i is the variance in the experimental data.
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11OHA4 → 11KA4 via 11βHSD2


















11OHA4 → 11KA4 via 11βHSD2


















11OH5αDione → 11K5αDione via 11βHSD2

















11OH5αDione → 11K5αDione via 11βHSD2


















11OHAST → 11KAST via 11βHSD2

















11OHAST → 11KAST via 11βHSD2
Figure 6.3: Model fit (solid lines) with 95% confidence intervals (grey areas) to
experimental 11βHSD2 data (points). The experiments were performed in triplicate,
with the variance indicated by the error bars.
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Table 6.4: Fitted parameter values for 11βHSD2 kinetics with their respective 95%
confidence intervals shown in brackets.
Substrate Vmax (μM/h) Km (μM)
11OHA4 0.286 (0.264 - 0.311) 1.031 (0.810 - 1.31)
11OH5αDione 2.342 (0.307 - 4.684) 18.32 (1.98 - 36.64)
11OHAST 0.125 (0.086 - 0.213) 2.476 (1.34 - 5.71)
6.2.1.2 Identifiability analysis
The identifiability of all the newly determined parameter values were tested. The
log-likelihood ratio test was used to determine the 95% confidence intervals as well as
whether the parameter values are identifiable. The functions profileLikelihood and
likelihoodRatioPlot of the package IdentifiabilityAnalysis were used to test
the identifiability of the parameters and create the profile likelihood plots. All of the
estimated values were identifiable except for the Vmax and Km values for the conversion
of 11OH5αDione to 11K5αDione. These two values were practically non-identifiable,
with a 95% confidence interval that is lower bound, but not upper bound. With
the experimental data used for model parameterisation, the substrate concentrations
were not high enough to saturate the enzyme, therefore there is no upper limit to the
confidence interval. In the analysis shown above, 2 times the parameter value is used for
the upper limit of the confidence interval if the parameter value was not identifiable. All


















































































































































































































































Km for 11OHAST → 11KAST via 11βHSD2
Figure 6.4: Profile likelihood plots of the 11βHSD2 parameters. The solid blue
lines are the 95% confidence intervals that constrain the fitted parameter value, indicated
by the dashed blue line. The red lines indicate the 95% confidence threshold value.
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6.2.1.3 Validation
The parameter value estimations were validated by using these values to predict the
outcome of run-out experiments of another transfection. To account for the differences in
transfection efficiency between the two sets of data, the initial rate of conversion of 1 μM
11OH5αDione was compared between the two experiments. The ratio of the difference
in the initial rates were used as a variable multiplier while predicting the outcome of
the run-out experiment for the conversion of 11OH5αDione to 11K5αDione. With this
variable multiplier for 1 μM 11OH5αDione conversion, the run-out experiment of 1 μM
11OHA4 to 11KA4 was also predicted as validation. The model predictions and the run
out data are shown in Figure 6.5.


















11OHA4 → 11KA4 via 11βHSD2


















11OH5αDione → 11K5αDione via 11βHSD2
Figure 6.5: Model validation: prediction (solid lines) of 11βHSD2 run-out data
(points). The 95% confidence intervals of the model prediction is shown by
the grey ares.
6.2.2 Newly determined parameter values: 3αHSD
To the best of our knowledge, no kinetic data has been collected describing the dynamics
of 3αHSD. Mass action kinetics for this enzyme are assumed and for each 3αHSD reaction
only one parameter value is fitted for, which describes the ratio of Vmax/Km. These
parameter values are fitted for during model construction with the use of C42B cancer
cell data as this is the only data available that includes 3αHSD kinetics. This is further
addressed in the following section.
6.3 Model construction and validation
The Vmax and Km pairs of all the enzymes (except 3αHSD) have been determined.
These parameter value pairs have been determined in transfected cells. These values are
then combined to construct a complete model for steroid biosynthesis in prostate cancer
cells. The transfection efficiency of each enzyme is different than the expression level of
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the enzymes in the cancer cells. To adjust for the differences in enzyme expression, a
variable multiplier is fitted for for each of the enzymes. Data collected from prostate
cancer cell line C42B were used to construct the model. This cell line expresses the
enzymes AKR1C3, 17βHSD2, SRD5A, 11βHSD2, and 3αHSD. Three variable multipliers
were fitted for: one each for SRD5A and 11βHSD2, and the third multiplier adjusted
for the expression of both AKR1C3 and 17βHSD2. The ratio of AKR1C3 to 17βHSD2
expression, as published in [7], was included in the fitting and therefore it was possible
to fit for one less multiplier. These variable multiplier values are incorporated into
the model to ensure that the model describes the correct relative activities of the enzymes.
6.3.1 3αHSD kinetic parameters
Mass action kinetics for this enzyme are assumed and only one parameter value is
fitted for, for each 3αHSD reaction. These mass action parameter values were fitted for
along with the enzyme expression variable multipliers. The same parameter estimation
technique of nonlinear regression and minimising of the objective function 6.5 was
used for 3αHSD. The mass action kinetic values k5aDione, k5aDHT, kAST, and k3aAdiol,
k11OH5aDione, k11K5aDione, k11K5aDHT, k11OHAST, and k11KAST were fitted for.
6.3.2 C42B data for model construction and validation
Time course datasets from three experiments in C42B cells were collected. To construct
the model, the data of one of the experiments were used to fit for all variable multipliers
and 3αHSD parameters. As validation, the model is then used to predict the outcome of
the other two datasets. Two datasets were used for validation and only one was used for
model construction as two of the datasets were biological repeats. Of the two datasets
that are biological repeats, one was used for construction and the other was used for
validation. The third dataset was therefore kept as a validation dataset, otherwise the
only dataset used for validation would have been one that was nearly identical to a
dataset used for model construction.
6.3.3 Model construction
The dataset used for model construction consists of four time courses from one trans-
fection. The data is indicated as Transfection 1 in Table 6.5. Figure 6.6 shows the
model fit to the model construction data. During this fit, the 38 previously determined
parameter values of AKR1C3, 17βHSD2, SRD5A, and 11βHSD2 were kept as is. The
three variable multipliers (α, β and γ), for the relative expression of these enzymes,
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Table 6.5: C42B data for model construction and validation
Dataset Substrate concentration Products measured
Transfection 1 0.1 uM 11OHA4 All metabolites in Fig. 6.2
1.0 uM 11OHA4 All metabolites in Fig. 6.2
0.1 uM A4 All metabolites in Fig. 6.1
1.0 uM A4 All metabolites in Fig. 6.1
Transfection 2 1.0 uM 11OHA4 11KA4, 11KT, 11K5αDHT, 11KAST
1.0 uM A4 T, 5αDione, 5αDHT
Transfection 3 0.1 11OHA4 All metabolites in Fig. 6.2
1.0 11OHA4 All metabolites in Fig. 6.2
0.1 A4 All metabolites in Fig. 6.1
1.0 A4 All metabolites in Fig. 6.1
were fitted for, along with the nine mass action parameter values for the nine reactions
catalysed by 3αHSD (see rate equations 6.6a to 6.6l and equations 6.7a to 6.7p). The
ODEs (equation 6.9a to 6.9l) were fitted to a single set of experimental data and the 12
unknowns were determined by minimising an objective function with weighted nonlinear
least squares regression. A total of 12 unknown values were fitted for with a single
dataset, consisting of four time courses. Prior to running a full identifiability analysis on
the 3αHSD parameter values, these values were varied with a factor 10 smaller and larger
than the estimated value. These changes did not affect the variables in the top two tiers
of the pathways in Figures 6.1 and 6.2, indicating that these parameter values are not
identifiable. Despite the limited amount of data available for model construction and the
non-identifiability of the 3αHSD parameter values, a fairly accurate fit was obtained, as
can be seen in Figure 6.6. The fitted values of these three multipliers were incorporated
into the previously determined parameter values for AKR1C3, 17βHSD2, SRD5A, and
11βHSD2. These updated parameter values, which now include the relative enzyme
activities, and the newly determined 3αHSD values are shown in Tables 6.6 and 6.7. The
parameter values determined for 3αHSD were used as is, despite their non-identifiability,
as this did not affect the success of the model in terms of describing the dynamics of the
metabolite synthesis of the top two tiers of the pathways in Figures 6.1 and 6.2
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Rate equations
v1 =

































3aHSD · [5αDione] (6.6i)
v10 = k
5aDHT
3aHSD · [5αDHT ] (6.6j)
v11 = k
AST
3aHSD · [AST ] (6.6k)
v12 = k
3aAdiol
3aHSD · [3αAdiol] (6.6l)
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Rate equations
v13 =













































3aHSD · [11OH5αDione] (6.7l)
v25 = k
11K5aDione
3aHSD · [11K5αDione] (6.7m)
v26 = k
11K5aDHT
3aHSD · [11K5αDHT ] (6.7n)
v27 = k
11OHAST
3aHSD · [11OHAST ] (6.7o)
v28 = k
11KAST
3aHSD · [11KAST ] (6.7p)
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[T ] = −v1 − v4 − v8 (6.9a)
d
dt
[5αDHT ] = v2 − v5 + v8 − v10 + v12 (6.9b)
d
dt
[5αDione] = −v2 + v5 + v7 − v9 + v11 (6.9c)
d
dt
[AST ] = −v3 + v6 + v9 − v11 (6.9d)
d
dt
[3αAdiol] = v3 − v6 + v10 − v12 (6.9e)
d
dt
[11OH5αDione] = −v14 + v21 − v24 + v27 (6.9f)
d
dt
[11OHAST ] = −v15 + v24 − v27 (6.9g)
d
dt
[11KA4] = v13 − v16 + v19 − v22 (6.9h)
d
dt
[11K5αDione] = v14 − v17 + v20 + v22 − v25 + v28 (6.9i)
d
dt
[11KAST ] = v15 − v18 + v25 − v28 (6.9j)
d
dt
[11KT ] = v16 − v19 − v23 (6.9k)
d
dt
[11K5αDHT ] = v17 − v20 + v23 − v26 (6.9l)
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Figure 6.6: Model construction: fitting of one C42B dataset to determine rel-
ative enzyme expression and all 3αHSD mass action parameter values.
Table 6.6: Classic androgen parameter values in C42B CRPC
Parameter μM/h Parameter μM
Vmax A4AKR1C3 0.0005 Km A4AKR1C3 0.06
Vmax 5aDioneAKR1C3 0.0004 Km 5aDioneAKR1C3 0.12
Vmax ASTAKR1C3 0.0014 Km ASTAKR1C3 0.27
Vmax T17BHSD2 0.0019 Km T17BHSD2 5.08
Vmax 5aDHT17BHSD2 0.0012 Km 5aDHT17BHSD2 3.77
Vmax 3aAdiol17BHSD2 0.0021 Km 3aAdiol17BHSD2 5.86
Vmax A4SRD5A 0.1681 Km A4SRD5A 12.1
Vmax TSRD5A 2.384 Km TSRD5A 373.0
k 5aDione3aHSD 4.096 k 5aDHT3aHSD 0.1660
k AST3aHSD 4.639 k 3aAdiol3aHSD 10.29
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Table 6.7: 11-Oxygenated androgen parameter values in C42B CRPC cells
Parameter μM/h Parameter μM
Vmax 11OHA411BHSD2 0.0386 Km 11OHA411BHSD2 1.03
Vmax 11OH5aDione11BHSD2 0.3111 Km 11OH5aDione11BHSD2 18.3
Vmax 11OHAST11BHSD2 0.0166 Km 11OHAST11BHSD2 2.48
Vmax 11KA4AKR1C3 0.0074 Km 11KA4AKR1C3 0.11
Vmax 11K5aDioneAKR1C3 0.0151 Km 11K5aDioneAKR1C3 0.23
Vmax 11KASTAKR1C3 0.0162 Km 11KASTAKR1C3 0.34
Vmax 11KT17BHSD2 0.0022 Km 11KT17BHSD2 9.11
Vmax 11K5aDHT17BHSD2 0.0033 Km 11K5aDHT17BHSD2 7.72
Vmax 11OHA4SRD5A 0.0963 Km 11OHA4SRD5A 30.4
Vmax 11KA4SRD5A 0.3973 Km 11KA4SRD5A 90.7
Vmax 11KTSRD5A 0.5348 Km 11KTSRD5A 918
k 11OH5aDione3aHSD 4.820 k 11K5aDione3aHSD 0.2918
k 11K5aDHT3aHSD 0.7557 k 11OHAST3aHSD 0.4855
k 11KAST3aHSD 14.09
6.3.4 Model validation
The remaining two C42B datasets were used for model validation. As mentioned above,
the experimental conditions of the one experiment were the same as the experimental
conditions of the model construction dataset i.e. these two datasets are biological
repeats. This dataset consists of four time courses and is indicated as Transfection 3 in
Table 6.5. The prediction of these experimental results are shown in Figure 6.7. The
other experiment consists of two time courses and is indicated as Transfection 2 in Table
6.5. The model prediction of this experiment is shown in Figure 6.8.
Fig. 6.7A shows that the model overestimates the conversion of 11KA4 to 11KT
with an initial concentration of 0.1 μM 11OHA4. Fig. 6.7B shows that at the higher
initial concentration of 1.0 μM 11OHA4 the model gives an accurate prediction of the
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experimental data. At the lower initial concentration of 0.1 μM A4 (Fig. 6.7C), the
model gives an qualitative prediction of the experimental results, however at the higher
initial concentration of 1.0 μM A4 (Fig. 6.7D) the model returns an underestimation
of the synthesis of 5αDHT. Similar results are seen in Fig. 6.8B for the same initial
concentration of A4, the model underestimates the synthesis of 5αDHT. In this case the
consumption of A4 is also underestimated. In Fig. 6.8A, with an initial concentration
of 1.0 11OHA4, the consumption of 11OHA4, and the synthesis of intermediates and
products are underestimated.






































































































Figure 6.7: Model validation: predicting the results of C42B datasets (Trans-
fection 3).



















































6.4. Identifying possible treatment targets
6.4 Identifying possible treatment targets
The following section contains steady state and metabolic control analysis (MCA) of the
CRPC model in C42B cells. Since we need a steady state for the MCA, we first adapt
the model so that it can reach steady state.
6.4.1 Steady state analysis
Figure 6.9 shows the steady state concentrations of all the steroid intermediates and
products with fixed concentrations of 3.9 nM A4 and 3.7 nM 11OHA4. These concen-
trations represent the physiological serum concentrations of A4 and 11OHA4 in men
[94]. All intermediates and products are removed from the system at a constant rate of
0.1 h-1 times the metabolite concentration. This technique of steady state analysis of a
steroid hormone model is similar to the method used by Nguyen et al in [81]. According
to the model simulations, when an equal supply of A4 and 11OHA4 is present in the
cell, 11KA4 and 11KT have the highest steady state concentrations.
These results are robust. Varying the supply of A4 and 11OHA4 returns nearly the exact
same results. Nguyen et al [81] suggests a removal value of metabolite intermediates
and products between 0.01 and 1.0 time-1, they however use the value of 0.1 time-1 in
their analysis. Changing the removal of metabolite intermediates and products to 0.01
h-1 shows that 11KT has the highest steady state value. Increasing the removal value to






































































Figure 6.9: Steady state concentrations (μM) of classic androgens (blue) and
11-oxygenated androgens (green) with a supply of 10 nM 11OHA4 and A4 per hour
and removal of all intermediates and products at a rate of 0.1 h-1 times the concentration.
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6.4.2 Flux control and concentration control
The following section addresses the flux control and concentration control of the
enzymes, this is shown in the heat maps of Figures 6.12 and 6.13. The fluxes
are numbered from J1 to J28. Figures 6.10 and 6.11 show which flux corresponds to
which branch in either the classic androgen or 11-oxygenated androgen synthesis pathway.
6.4.2.1 3αHSD
The enzyme 3αHSD has strong positive control over its own reactions, except the reaction
J26 over which it has a less strong control. The only reaction, other than its own, that
it has any significant effect on is the reaction J20 (the conversion of 11K5αDHT to
11K5αDione by 17βHSD2), see Fig. 6.12.
3αHSD has very little control over any metabolite concentrations, except for a strong
negative control over the concentration of 11KAST. This enzyme has little control over
the processes leading to the potent androgens T, 5αDHT, 11KT, and 11K5αDHT, see
Fig. 6.13.
6.4.2.2 11βHSD2
This enzyme has strong positive control over nearly every reaction in the 11-oxygenated
pathway. Not only does it have control over it’s own reactions (J13, J14, and J15), but
it has positive control over all AKR1C3 and 17βHSD2’s reactions (J16, J17, and J18 and
J19 and J20 respectively) in the 11-oxygenated pathway. It also has control over two of
SRD5A’s reactions (J22 and J23), and three of 3αHSD’s reactions (J25, J26, and J28),
see Fig. 6.12.
11βHSD2 has little control over any of the metabolites in the top tier of the 11-oxygenated
pathway (11KA4 or 11KT), but it has a strong positive control over the concentrations
of all the other metabolites in this pathway, see Fig. 6.13. 11βHSD2 has virtually no
control over any of the reactions or metabolite concentrations of the classic androgen
pathway.
6.4.2.3 SRD5A
This enzyme has most control over the system in both the classic and 11-oxygenated
androgen pathways. It has strong positive control over all the reactions except for J1
and J4 in the classic pathway, and J13, J16, and J19 in the 11-oxygenated pathway.
These reactions are all in the top tiers of the pathways. SRD5A has strong positive
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control over all the reactions in the middle and bottom tiers of the pathways, see Fig. 6.12.
SRD5A has insignificant control over the concentration of T in the classic pathway,
but has strong positive control over all metabolites in the middle and bottom tiers of
the classic pathway. In contrast, although SRD5A has little control over the reactions
of the top tier of the 11-oxygenated pathway, it has strong positive control over the
concentrations of the metabolites in the top tier (11KA4 and 11KT). SRD5A has strong
positive control over all metabolite concentrations of the middle and bottom tiers of the
11-oxygenated pathway, except for 11OH5αDione and 11OHAST, see Fig. 6.13.
6.4.2.4 17βHSD2
This enzyme has strong positive control over it’s own reactions in both pathways (J4, J5,
J6, J19, and J20), but has little control over any other reaction, see Fig. 6.12. 17βHSD2
also has insignificant control over any metabolite concentration, see Fig. 6.13.
6.4.2.5 AKR1C3
In the classic androgen pathway, AKR1C3 has strong positive control over it’s own
reactions and all the reactions catalysed by 17βHSD2 (J1, J2, and J3, and J4, J5,
and J6 respectively), as can be seen in Figure 6.12. It also has strong positive control
over all the reactions downstream of itself, i.e reaction J8 catalysed by SRD5A and
reactions J10 and J12 catalysed by 3αHSD. In contrast, AKR1C3 does not have have
very strong control over any of the reactions in the 11-oxygenated pathway. It has
moderate positive control over all reactions catalysed by itself and 17βHSD2 (J16,
J17, and J18 and J19 and J20 respectively). AKR1C3 has moderate negative control
over the reactions running from 11KA4 to and between 11K5αDione and 11KAST
(J22, J25, and J28). It has moderate positive control over the reactions running from
11KT to 11K5αDHT and the further conversion of 11KDHT (J23 and J26), see Fig. 6.12.
In the classic androgen pathway, AKR1C3 has strong positive control over the con-
centrations of T, 5αDione, and 3αAdiol. In the 11-oxygenated pathway, AKR1C3 has
moderate negative control over the concentrations of the metabolites of the middle tier
(11OH5αDione, 11K5αDione, and 11KDHT) and moderate positive control over the con-
centrations of the metabolites of the bottom tier (11OHAST and 11KAST), see Fig. 6.13.
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Figure 6.10: Schematic representation of the classic androgen and 5αDione




























Figure 6.11: Schematic representation of the 11-oxygenated androgen biosyn-
thesis pathway. The fluxes through the pathway are numbered from J13 to J28.
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Figure 6.12: Heat map of the flux control coefficients of the enzymes AKR1C3,
17βHSD2, SRD5A, 11βHSD2, and 3αHSD on the flux through the branches
J1 to J28 (see Fig. 6.10 and 6.11).
Figure 6.13: Heat map of the concentration control coefficients of the enzymes
AKR1C3, 17βHSD2, SRD5A, 11βHSD2, and 3αHSD on the concentrations
of the metabolites T, 5αDione, 5αDHT, AST, 3αAdiol, 11KA4, 11KT, 11OH5αDione,
11K5αDione, 11K5αDHT, 11OHAST, and 11KAST.
The MCA shows that the three enzymes with the most control over the flux through the
system as well as the most control over the majority of the metabolite concentrations
are AKR1C3, SRD5A and 11βHSD2, however, 11βHSD2’s control is limited to the fluxes
and metabolites of the 11-oxygenated pathway.
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6.5 Increased expression of enzymes
Any variations in the expression levels of the enzymes can be simulated with the model.
Here we look at the changes in the steady state concentrations of all intermediates and
products while the expression level of the enzymes are increased. In Figure 6.14 the
enzyme expressions are increased 100%, one enzyme at a time. With increased AKR1C3
expression, the steady state concentrations of T, 5αDHT, and 3αAdiol increase about
100%, while the steady state concentrations of 11KT and 11K5αDHT increase about
50% and 20% respectively. The increased AKR1C3 activity leads to a decreased steady
state concentrations in 5αDione, AST, 11KA4, 11K5αDione, and 11KAST, while it has
no effect on 11OH5αDione and 11OHAST. The increased expression of 17βHSD2 has
little effect on any of the intermediates and products with less than 1% change in any
of the metabolite concentrations. The increase in SRD5A expression increases all the
metabolite steady state concentrations by around 100%, except T, 11KA4, and 11KT,
which is decreased by less than 10%. The increase in 11βHSD2 expression leads to an
increase in 11KA4, 11KT, 11K5αDione, 11K5αDHT, and 11KAST of around 100%.
The steady state concentrations of 11OH5αDione and 11OHAST are reduced by
between 5% and 10%, while the other metabolites are unaffected. 11K5αDHT is the
metabolite most influenced by the increased expression of 3αHSD; the concentration
thereof is decreased by nearly 50%. The other metabolites decreased are 3αAdiol,
11OH5αDione, and 11KAST. The effect on the steady state concentration of the
remaining metabolites are less than 1%. The only case where the up-regulation of an
enzyme has any significant effect on lowering the synthesis of potent androgens is the
up-regulation of 3αHSD which results in a decrease in 11K5αDHT synthesis of nearly 50%.
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100% increase in 3αHSD expression
Figure 6.14: Percentage change in steady state concentrations of metabolites





In Figures 6.15 and 6.16 one can see the steady state concentrations of the steroid
hormones with inhibition of the enzymes AKR1C3, 17βHSD2, SRD5A, 11βHSD2, and
3αHSD. Full non-competitive inhibition of the enzymes have been simulated. Only the
inhibition of AKR1C3 limits the synthesis of all potent androgens (T, 5αDHT, 11KT,
and 11K5αDHT) completely. Inhibition of any of the other enzyme still leads to the
synthesis of two or more of these androgens. Inhibition of 17βHSD2 has little effect on
limiting the synthesis of the potent androgens. Inhibition of either SRD5A or 3αHSD
limits 5αDHT and 11K5αDHT synthesis, but has little effect on the synthesis of T and
11KT. Even though SRD5A has strong control over the flux of most of the branches
in the two pathways, it does not have much control over the branches leading to the
synthesis of T and 11KT (Fig. 6.12). If the goal is to limit the synthesis of only 11KT
and 11K5αDHT, the enzyme 11βHSD2 would be a possible target, as inhibition thereof
limits the synthesis of potent 11-oxygenated androgens. However, the inhibition of















































































































































Figure 6.15: Steady state concentrations of metabolites with 100% inhibition
























































































































































































































Figure 6.16: Steady state concentrations of metabolites with 100% inhibition
of SRD5A, 11βHSD2, and 3αHSD.
Conclusion
With relatively equal serum concentrations of A4 and 11OHA4, as is seen physiologically
[94], the 11-oxygenated androgens, 11KA4 and 11KT, have higher steady state concen-
trations than the classic androgens. MCA showed that 11βHSD2 has strong control over
nearly the entire 11-oxygenated androgen pathway, but none over the classic androgen
pathway, while SRD5A is the enzyme with most control over both both pathways. MCA
also showed that 17βHSD2 and 3αHSD has little control over the system other than their
own reactions, while AKR1C3 has strong control over some of the reactions of the classic
androgen pathway, but has moderate control over some reactions of the 11-oxygenated
pathway.
Model simulations of increased enzyme expression showed increased steady state
concentrations of potent androgens (T, 5αDHT, 11KT, and 11K5αDHT) with increased
expression of AKR1C3. Increased expression of 11βHSD2 had little effect on T and
5αDHT, but results in a great increase in 11KT and 11KT5αDHT steady state concen-
trations. Increased expression of SRD5A leads to a slight decrease in T and 11KT steady
state concentrations, but increases the concentrations of 5αDHT and 11KT5αDHT. The




androgens with increased expression thereof are 17βHSD2 and 3αHSD, however the
effects of 17βHSD2 is less than 1% change in the steady state concentrations. The
increased 3αHSD expression reduces the concentration of 11K5αDHT by nearly 50%.
Model simulations of enzyme inhibition showed that AKR1C3 is the only enzyme that
limits the synthesis of all four of the potent androgens with inhibition thereof. The
inhibition of 11βHSD2 only limits the synthesis of 11-oxygenated androgens.
In this chapter a model is constructed for the conversion of classic androgens and
11-oxygenated androgens in C42B prostate cancer cells. The model was parameterised
with values from literature and parameter values derived from experimental data of
transfected cells. The model was then fitted to and validated against C42B cancer cell
data.
This chapter illustrates, with the use of a computational model, that there are three
possible treatment targets for limiting the synthesis of potent androgens in CRPC C42B
cells. The first is the inhibition of AKR1C3, which limits the synthesis of all four potent
androgens. The second is the inhibition of 11βHSD2, however, this will only limit the
synthesis of 11KT and 11K5αDHT. The third possible target is the up-regulation of
3αHSD, which limits the synthesis of 11K5αDHT. The model has only been validated
against C42B cancer cell data and possible future work could include the validation




The aim of this study was to develop models for three different steroidogenic pathways
and to use these models to address specific questions regarding these pathways. The first
pathway that was studied was the combined Δ4 and Δ5 pathways in the South African
Angora goat. It was previously suggested that the hypocortisolism seen in the Angora
goats originate from this part of the steroidogenic pathway as these goats synthesise
much more A4 relative to cortisol. Comparative in vivo studies in literature that were
conducted on Angora goats and two hardy species, the Merino sheep and the Boer
goat, showed that the main difference between the Angora goat and the hardy species is
increased CYP17 activity. The 3βHSD and CYP17 enzymes are the only two enzymes
catalysing the reactions of the Δ4 and Δ5 pathways [26–28, 118]. These enzymes are
multi-functional and as such, studying the dynamics of these enzymes as they compete
for the same steroid substrates is not trivial.
The research questions that were addressed in chapter 4 were the following: How does
the increased CYP17 activity of the Angora goat affect the flux through the pathway?
Which of the two enzymes, 3βHSD or CYP17, has the most control over the system and
where does the most control lie? How does a stress response change the flux through
the pathway and finally how does this all differ from a hardy species that does not suffer
from hypocortisolism?
To answer these questions two models were created: one for the Merino sheep, which
were used as a healthy control model and a second model which represents the altered
adrenal function in the South African Angora goat. The ovine model was constructed,
parameterised and validated with in vitro transfection data. The identifiability of the
parameter values were tested, whereafter simulations of the ovine model, which mimicked
the results found in [81] were used as model validation. The ovine model was also
validated against animal data collected from homogenised adrenal microsomes of Merino
sheep [28]. Data from the same study, but collected from Angora goats were then used to
construct the Angora model. This Angora model was then validated against transfection
data of another independent study [105].




each other and analysed under steady state conditions. The model simulations showed
that the steady state concentrations of the sex steroid precursor, A4, were higher and
the cortisol precursor, 17-OHPROG, were lower in the Angora model than the ovine
model. The models showed an increase in flux towards A4 and a decrease in flux towards
17-OHPROG as the activity of CYP17 is incrementally increased from that what we see
in the ovine model until it finally reaches the activity level of the Angora model. The
results of MCA of the two models showed that the control that both the CYP17 and the
3βHSD enzyme have on the pathway differ between the ovine and Angora models. There
are two points where the change in control is most significant: the point where PREG
is converted to either 17-OHPREG or PROG, and where 17-OHPREG is converted to
either DHEA or 17-OHPROG by CYP17 and 3βHSD respectively. Between the ovine
and Angora models there is a larger change in the flux control that both enzymes have
on the Δ5 than the reactions towards the Δ4 part of the pathway.
The models were also analysed under steady state conditions which simulate a response
to physiological stress. An increase in PREG concentration was simulated which repre-
sent the physiological response these animals have to cold stress. The relative conversion
of PREG to either 17-OHPROG or A4 were analysed with increasing concentrations of
PREG. The ovine model showed a physiological response one would expect to see in
mammals with healthy steroidogenic function: an increase in 17-OHPROG synthesis
relative to A4 synthesis with an increase in PREG. The Angora model also responded
to the simulated physiological stress, however, the levels of 17-OHPROG synthesised
relative to A4 is much lower than that seen in the ovine model. These results correspond
to the results seen in in vivo studies, the South African Angora goat does respond to
physiological stress by increasing the synthesis of cortisol, this response is just much
lower than the response seen in hardy ovine species [26–28]. The models also show that
the Δ5 pathway is preferred in the Angora model with the flux through the Δ5 branches
being much higher than in the ovine model. Simulating a stress response also showed
that the two points in the pathway mentioned above (the fork at PREG and the fork at
17-OHPREG) differ significantly between the ovine and the Angora models. These two
points both contribute to maintaining the higher flux through the Δ5 pathway seen in
the Angora goat.
These results would suggest that the hypocortisolism seen in the South African Angora
goat is not caused by a glitch at only one specific point in the steroidogenic pathway.
These are not promising results in terms of identifying possible treatment targets. With
South African mohair being of superior quality and the South African Angora goats
being the only population suffering from hypocortisolism [12, 26], there might be a
correlation between mohair quality and either decreased cortisol synthesis or increased




the hardiness of the South African Angora goat population remains to be seen [107].
The second steroidogenic pathway that was studied with the use of computational
modelling is the combined pathways of the classic androgens and the 11-oxygenated an-
drogens in the human liver. 11KT is a potent androgen and the effects of 11-oxygenated
androgens should be considered along with the effects of the classic androgens as
these steroids are all pooled and catalysed by the same enzymes [87, 108]. However,
the 11-oxygentated androgens have not yet been studied as extensively as the classic
androgens. As the 5α reduction products of both the classic androgens and the
11-oxygenated androgens are also potent androgens while the 5β reduction products are
not, knowing the relative synthesis of each of these groups of steroids are of importance.
The classic androgens, T and A4, are converted to their 5α reduction products, 5αDHT
and 5αDione, by either SRD5A1or SRD5A2, while the 11-oxygenated androgens, 11KT
and 11KA4, are converted to their 5α reduction products, 11K5αDHT and 11K5αDione.
AKR1D1 converts these androgens to their 5β reduction products; T, A4, 11KA4,
and 11KT are converted to 5βDHT, 5βDione, 11K5βDHT, and 11K5βDione respec-
tively. The research question that was addressed in chapter 5 is whether the relative
conversion of the classic and the 11-oxygenated androgens to their respective 5α or
5β reduction products could be predicted in the human liver with a computational model.
Chapter 5 contains the construction and validation of this model with transfection data.
The model was constructed and validated with data collected from two independent
transfections. The identifiability of the parameter values were also tested. The model
was studied at physiological steady state with 1:1:1 enzyme expression levels. The
physiological expression levels of the enzymes AKR1D1, SRD5A1, and SRD5A2 were
then incorporated into the model whereafter the model was again studied at steady state.
The results showed that at enzyme expression levels of 1:1:1, the 5α reduction of T, A4,
11KT, and 11KA4 are the preferred reactions. This is because SRD5A2 has the highest
efficiency towards these androgens. However, once the physiological expression levels
of the enzymes are included into the model, the 5β reduction of the androgens are the
preferred reactions as the expression level of AKR1D1 is nearly 16 times higher than the
expression of SRD5A1 and nearly eight times higher than the expression of SRD5A2.
Given physiological plasma levels if T and 11KT in men and women, the model was
able to predict the conversions of these androgens to their 5α and 5β reduction products.
The 5β reduction products, 5βDHT and 11K5βDHT, have the highest steady state
concentrations. Of the potent 5α reduction androgen products, 5αDHT and 11K5αDHT,
the levels of 5αDHT are higher in men, while women tend to have higher levels of the




The values used for the physiological expression of the enzymes were the relative values
of the RNA expression of these enzymes in human liver cells taken from The Human
Protein Atlas database. Future work would be to include the expression levels of the
enzymes determined experimentally and completing additional validation experiments
as the RNA expression of the enzymes are not necessarily an absolute indication of the
enzyme expression levels.
The third and final steroidogenic pathway studied with the use of computational
modelling is the combined dynamics of the 5αDione androgenic pathway and the 11-
oxygenated androgenic pathway in C42B CRPC cells. The involvement of 11-oxygentated
androgens in CRPC has increasingly gained interest in the recent years [7, 87, 108]. The
research question that was addressed in chapter 6 is whether it is possible to construct
a model that describe the combined dynamics of the 5αDione androgenic pathway and
the 11-oxygenated androgenic pathway in C42B CRPC cells and in the process identify
possible treatment targets.
The reactions of the 5αDione and the 11-oxygenated androgenic pathway is catalysed
by the following enzymes: AKR1C3, 17βHSD2, SRD5A, 3αHSD, and 11βHSD2. All five
enzymes are present in the 11-oxygenated androgen pathway, while only the first four
are present in the 5αDione pathway. The model was constructed and parameterised with
a combination of transfection data, C42B cancer cell data and previously determined
parameter values. The kinetic parameters of 11βHSD2 were fitted for with the use
of transfection data as these parameters had not yet been determined. The mass
action kinetic parameters for 3αHSD were fitted for with the use of time course data
collected from C42B cancer cells. The parameter values of SRD5A have previously been
determined by our group, although they have not yet been published, and the parameter
values for AKR1C3 and 17βHSD2 were taken from literature [7]. The identifiability of
the 11βHSD2 parameter values were tested whereafter the model was validated against
C42B cancer cell time course data.
The model was then studied at physiological steady state and MCA was completed.
The results showed that the enzymes AKR1C3 and 11βHSD2 have strong control over
a large part of the classic and 5αDione, and the 11-oxygenated pathways respectively,
while SRD5A has strong control over a large part of both pathways. MCA showed that
neither 17βHSD2 nor 3αHSD had any significant control over the reaction of the pathway
other than their own reactions. The effects of increased enzyme expression as well as
enzyme inhibition were simulated. Increasing the expression of these enzymes identified
one possible treatment target. The up-regulation of 3αHSD reduces the concentration
of the potent androgen 11K5αDHT. The inhibition of enzymes identified two possible




androgens and the inhibition of 11βHSD2 to limit the synthesis of the 11-oxygenated
potent androgens, 11KT and 11K5αDHT.
Possible future work would entail parameterising the model for other CRPC cell lines
and completing additional validation experiments as the enzyme kinetics might be
different in other cell lines.
To complete the analysis shown in this thesis the add-on Mathematica package
IdentifiabilityAnalysis was created. The aim of creating the package was to allow
the user to parameterise an ODE based model with time course type data with very little
additional coding required. In the process the user can also test the identifiability of the
model parameters and create profile likelihood plots which give a visual representation
of the parameter identifiability and confidence intervals.
The package consists of five functions. The function objectiveFuncion returns the SSR
value between the model and data. This function returns a single value as it calculates the
SSR for a specific set of parameter values. The function minimizeObjectiveFunction
is similar to objectiveFuncion, however, this function scans over the possible solution
space while minimising the SSR values and in the process returns the optimal parameter
value estimations. The profile likelihood for all the parameters are calculated by the
function profileLikelihood and the likelihoodRatioTest function completed the
likelihood ratio test on the profile likelihood values at a specific Chi-square distribution
value, as selected by the user, corresponding to one degree of freedom and the desired
confidence level. The function likelihoodRatioPlot conducts the same test as the
function likelihoodRatioTest, however, the results are returned as a profile likelihood
plot.
This study confirms the importance of each step of the model construction process.
Chapter 4 highlighted the crucial role that identifiability analysis plays in experimental
design. In the other two research chapters in this study, identifiability analysis was only
used to test the identifiability of newly determined parameters, as well as calculating
their respective confidence intervals. For the construction of the ovine model in chapter
4, identifiability analysis aided in showing where there was a lack of experimental data.
Identifiability analysis allowed us to determine which parameters were not identifiable
and which datasets would need to be added to improve the identifiability. Therefore
only a few, very specific additional experimental datasets were needed. Chapter 5 is
an example of where the inclusion of a few non-identifiable parameters in a model
still results in a usable model. Although the ovine model in chapter 4 also included
non-identifiable parameters, these parameters corresponded with a branch in the




the modelling of that particular pathway. The non-identifiable parameters seen in
chapter 5 played a more prominent role in the model. It must be said that all cases
of non-identifiability were practical non-identifiability, which only resulted in very wide
parameter confidence intervals. As such, the use of these parameters in the model,
although technically not ideal, still resulted in a useful model. Chapter 6 shows the diffi-
culties in combining parameter values from literature with newly determined parameter
values from experimental data. This chapter highlights the importance of sufficient vali-
dation data and the pit fall of using construction and validation data that are too similar.
There are similarities in the structure of the androgenic pathways discussed in this study,
however, there is variation in the roles of these pathways in different organs and organisms.
These differences can be attributed to varied protein expression levels and differences in
the levels of steroids in circulation. Therefore the comparison of models could be extended
to the steroidogenic pathways in different organs of different organisms. The results in
this study reinforce the importance of statistical and analytical techniques used during























































































































Figure 6.17: Identifiability analysis of 3βHSD V max2, Km17OHPreg and Km17OPHProg for

























































































































Figure 6.18: Identifiability analysis of 3βHSD V max3, KmDHEA and KmA4 for the con-


















































































Figure 6.19: Identifiability analysis of CYP17 V max1 and KmPreg for the conversion of















































































Figure 6.20: Identifiability analysis of CYP17 V max2 and Km17OHPreg for the conversion


















































































































Figure 6.21: Identifiability analysis of CYP17 V max3, V max4 and KmProg for the con-






































































































































































Km for 11KT → 11K5βDHT via AKR1D1
Figure 6.22: Identifiability analysis of AKR1D1 V max and Km for the conversion of T




































































































































































Km for 11KT → 11K5αDHT via SRD5A1
Figure 6.23: Identifiability analysis of SRD5A1 V max and Km for the conversion of T






























































































































































Km for 11KT → 11K5αDHT via SRD5A2
Figure 6.24: Identifiability analysis of SRD5A2 V max and Km for the conversion of T









































































































































































Km for 11KA4 → 11K5βDione via AKR1D1
Figure 6.25: Identifiability analysis of AKR1D1 V max and Km for the conversion of A4






























































































































































Km for 11KA4 → 11K5αDione via SRD5A1
Figure 6.26: Identifiability analysis of SRD5A1 V max and Km for the conversion of A4
































































































































































Km for 11KA4 → 11K5αDione via SRD5A2
Figure 6.27: Identifiability analysis of SRD5A2 V max and Km for the conversion of A4
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